 159 Solutions |
Acquired by IQVIA, May 2018 |
| 3-Dimensional Pharmaceuticals |
Acquired by J&J, Jan 2003, $88M |
| 3Clinical Research |
Acquired by Parexel, Mar 2004 |
| 3F Therapeutics |
Acquired by ATS Medical, Jan 2006 |
| 4-Antibody |
Bought by Agenus, Jan 2014, $10M |
| 454 Life Sciences |
Bought by Roche, Mar 2007, $454M |
| 4C Biotech |
Acquired by Henogen, Jul 2003 |
| 4SC-Discovery |
Sold to BioNTech Small Molecules, Apr 2016 |
| 510 Kardiac Devices |
Acquired by Keystone Heart, Jun 2020 |
| A&E Medical |
Acquired by Zimmer Biomet, Dec 2020, $250M |
| Aaren Scientific |
Bought by Zeiss, Jan 2014 |
| AavantiBio |
Acquired by Solid Biosciences, Dec 2022 |
| Ab Initio Biotherapeutics |
Acquired by Ligand Pharmaceuticals, Jul 2019, $12M |
| Abaxis |
Bought by Zoetis, Jul 2018 |
| abCRO |
Acquired by PPD, Apr 2009 |
| AbD Serotec |
Acquired from MorphoSys by Bio-Rad, Jan 2013, €53M |
| Abeta |
Assets bought by The Genetics Company, Jun 2003 |
| Abexxa Biologics |
Acquired by Boehringer-Ingelheim, Sep 2021 |
| ABF Pharmaceutical Services |
Acquired by GBF Group Pharma, 2017 |
| AbFero Pharmaceuticals |
Acquired by Pharmacosmos, Nov 2021, $225M |
| ABgene |
Bought by Apogent, Dec 2001 |
| Abgenix |
Bought by Amgen 2006 |
| Abide Therapeutics |
Acquired by Lundbeck, May 2019, $250M |
| Ability Biomedical |
Acquired by Medarex, $4.7M, Jul 2004 |
| Ablation Frontiers |
Acquired by Medtronic, Jan 2009, $225M |
| Ablynx |
Acquired by Sanofi, Jun 2018, $4.8B |
| Abmaxis |
Acquired by Merck, May 2006, $80M |
| Abraxis Bioscience |
Bought by Celgene, Jun 2010, $2.9B |
| Abrika Pharmaceuticals |
Acquired by Actavis, Apr 2007 |
| Absalus |
Acquired by EvoGenix, Apr 2005 |
| Abt Bio-Pharma Solutions |
Acquired by United Biosource, May 2010 |
| AbVitro |
Bought by Juno Therapeutics, Jan 2016, $125M |
| Acacia Biosciences |
Acquired by Rosetta Inpharmatics, Feb 1999 |
| Acambis |
Bought by Sanofi Pasteur, $276M, Sep 2008 |
| Accel Biotech |
Acquired by Ximedica, Jul 2016 |
| Acceleron Pharma |
Acquired by Merck, Nov 2021, $11.5B |
| AccelLAB |
Acquired by Charles River, Apr 2019 |
| Accelrys |
Bought by Dassault, 2014 |
| Acceptys |
Assets acquired by Patrys, Oct 2008 |
| ACCESS Oncology |
Acquired by Keryx Biopharmaceuticals, Jan 2004 |
| Access Scientific |
Acquired by Smiths Medical, May 2020 |
| AccessClosure |
Bought by Cardinal Health, May 2014 |
| Acclarent |
Bought by J&J, Dec 2009, $785M |
| Accovion |
Acquired by Clinipace, Apr 2015 |
| Accriva Diagnostics |
Acquired by Werfen/Instrumentation Laboratory, Jan 2017; fka ITC |
| Accugenix |
Bought by Charles River, Aug 2012 |
| Accuimage Diagnostics |
Acquired by Merge eFilm, Jan 2005 |
| Accuri Cytometers |
Acquired by BD, Mar 2011 |
| Ace Biosciences |
Acquired by Zymenex, Nov 2009 |
| ACEA Biosciences |
Acquired by Agilent, Nov 2018 |
| Acessa Health |
Acquired by Hologic, Aug 2020, $80M + Milestones |
| Acetylon Pharmaceuticals |
Acquired by Celgene, Dec 2016 |
| Achillion Pharmaceuticals |
Acquired by Alexion, Jan 2020, $930M |
| ACI Clinical |
Acquired by WCG, Mar 2018 |
| Aciex Therapeutics |
Acquired by Nicox, Oct 2014, $120M |
| Aclara Biosciences |
Bought by ViroLogics, Dec 2004, $160M |
| ACMI |
Acquired by Gyrus, 2005, $500M |
| Acolyte Biomedica |
Acquired by 3M, Feb 2007 |
| Acris Antibodies |
Acquired by OriGene Technologies, Sep 2015, became OriGene Europe |
| AcroMetrix |
Acquired by Life Technologies Jan 2010 |
| Acrymed |
Bought by Halyard (Halyard fka Kimberly-Clark Healthcare) |
| AcSentient |
Main assets acquired by Ista Pharmaceuticals, May 2002 |
| ACT Oncology |
Acquired by Precision for Medicine, Mar 2016, renamed Precision Oncology |
| Acta Vascular |
Acquired by CardioVasc, Apr 2007 |
| Actagene Oncology |
Acquired by Ignyta May 2013 |
| Actavis |
Acquired Allergan, $70B, Took Allergan name |
| Actelion Pharmaceuticals |
Acquired by J&J, Jun 2017, $30B |
| Actient Pharmaceuticals |
Acquired by Auxilium Pharmaceuticals, Apr 2013 |
| Actimis Pharmaceuticals |
Acquired by Boehringer Ingelheim 2008 |
| Activaero |
Bought by Vectura, €130M, Mar 2014 |
| ActivaTek |
Acquired by North Coast Medical |
| ActiViews |
Acquired by Stryker, Oct 2013, $30M |
| Activiomics |
Acquired by Retroscreen Virology Group, Mar 2014 |
| Activus Pharma |
Acquired by Sosei Group, Jun 2010, $5.6M |
| ActoGeniX |
Acquired by Intrexon, $60M, Feb 2015 |
| Acton Pharmaceuticals |
Acquired by Meda, Aug 2013 |
| Acuity Bio |
Acquired by Cook Biotech, May 2021 |
| Acuson |
Acquired by Siemens, Sep 2000, $700M |
| Acute Innovations |
Acquired by Acumed, Mar 2020 |
| Adamas Pharmaceuticals |
Acquired by Supernus, Nov 2021 |
| Adapt Pharma |
Bought by Emergent Biosolutions, Oct 2018, $635M + $100M milestones |
| Adaptate Biotherapeutics |
Acquired by Takeda, Jan 2022; Spun out of Gammadelta Therapeutics, Oct 2019 |
| ADC Biotechnology |
Acquired by Sterling Pharma Solutions, Apr 2021; aka ADCBIO |
| Additive Orthopaedics |
Acquired by Paragon 28, Jun 2021 |
| Addrenex |
Bought by Shionogi subsidiary Sciele, Nov 2009, $29M |
| Adello Biologics |
Acquired by Kashiv Pharma, Jan 2019 |
| Adenosine Therapeutics |
Bought by Clinical Data, Aug 2008, $11M |
| AdeptBio |
Bought by Asterand Bioscience, Aug 2015 |
| Aderis Pharmaceuticals |
Acquired by Schwarz Pharma, Jul 2005 |
| Adeza Biomedical |
Acquired by Cytyc, Apr 2007 |
| Adheron Therapeutics |
Bought by Roche, Oct 2015, $105M + $475 Milestones |
| Adhesys Medical |
Bought by Grunenthal, Apr 2017; fka Medical Adhesive Revolution |
| Admune Therapeutics |
Acquired by Novartis, Oct 2015 |
| Adnexus Therapeutics |
Bought by BMS, Sep 2007, $415M |
| Adolor |
Acquired by Cubist, Oct 2011, $415M |
| AdProtech |
Acquired by Inflazyme Pharmaceuticals, Apr 2004 |
| ADSM-Synchro Medical |
Acquired by Tyber Medical, Feb 2023 |
| Aduro Biotech |
Acquiring Chinook Therapeutics, Jun 2020, taking name |
| Advalytix |
Acquired by Beckman Coulter, 2009 |
| Advanced Analytical Technologies |
Acquired by Agilent, Mar 2018 |
| Advanced Biohealing |
Bought by Shire 2011, Now Shire Regenerative Medicine |
| Advanced Biotherapy |
Acquired for cash assets by energy company, Mar 2009 |
| Advanced Circulatory |
Bought by Zoll Medical, Mar 2015 |
| Advanced Circulatory Systems |
Acquired by Zoll, Dec 2014 |
| Advanced Clinical Research |
Acquired by Velocity Clinical, Jun 2019 |
| Advanced Influenza Technologies |
Acquired by CytoDyn, Jul 2006 |
| Advanced Inhalation Research |
Acquired by Alkermes, Feb 1999 |
| Advanced Memory Institute of NJ |
Acquired by Cenexel, Aug 2021 |
| Advanced Ocular Systems |
Acquired by scaffolding company, Dec 2008 |
| Advanced Stent Technologies |
Acquired by Boston Scientific Dec 2004 |
| Advanced Technology and Regenerative Medicine |
Bought by DePuy |
| AdvancedCath |
Acquired by TE Connectivity, Feb 2015, $190M |
| AdvanDx |
Acquired by OpGen, Jul 2015 |
| Advangen |
Acquired by Cellmid, May 2013 |
| Advantar Laboratories |
Acquired by Eurofins, Mar 2016 |
| Advion Bioanalytical |
Bought by Quintiles, Nov 2011 |
| ADViSYS |
Acquired by VGX Pharmaceuticals, 2007 |
| Aegera Therapeutics |
Acquired by PharmaScience, May 2011 |
| Aegis Therapeutics |
Acquired by Neurelis, Dec 2018 |
| Aelian Biotechnology |
Renamed Myllia, Apr 2022 |
| Aequus Biopharma |
Owned by CTI Biopharma, no news since 2012, no employees on LinkedIn |
| Aerie Pharmaceuticals |
Acquired by Alcon, Nov 2022, $770M |
| Aero Pharmaceuticals |
Acquired by Cocrystal Pharma, May 2011 |
| Aerocrine |
Bought by Circassia Pharmaceuticals, May 2015, $219M |
| AES Chemunex |
Bought by bioMerieux, May 2011 |
| Aesgen |
Acquired by MGI Pharma, Sep 2004 |
| Aesica Pharmaceuticals |
Bought by Consort Medical for $374M, Sep 2014 |
| AesRx |
Bought by Baxter, Jul 2014 |
| Aesthera |
Acquired by Solta Medical, Feb 2010 |
| Aevi Genomic Medicine |
Acquired by Cerecor, Feb 2020, $15.6M + $6.5M Milestones |
| Afexa Life Sciences |
Acquired by Valeant Oct 2011 |
| Affera |
Acquired by Medtronic, Sep 2022, $1B |
| Afferent Pharmaceuticals |
Bought by Merck, Jul 2016, $1.25B |
| Affinity BioReagents |
Acquired by Thermo Fisher, Jul 2008 |
| Affinium Pharmaceuticals |
Assets acquired by Debiopharm, Feb 2014 |
| Affinivax |
Acquired by GSK, Aug 2022 |
| Affomix |
Acquired by Illumina, Jul 2010 |
| Affymetrix |
Acquired by Thermo Fisher, Apr 2016, $1.3B |
| Afmedica |
Acquired by Angiotech, Sep 2005 |
| AGA Medical |
Acquired by St. Jude Medical, Oct 2010, $1.3B |
| Agalimmune |
Acquired by BioLineRx, Mar 2017, $6M |
| Agenovir |
Acquired by Vir Biotechnology, May 2018 |
| Agensys |
Acquired by Astellas Pharma, Nov 2007, $387M + $150M milestones |
| Agere Pharmaceuticals |
Acquired by Patheon, Mar 2015 |
| AGI Dermatics |
Acquired by Estee Lauder, Sep 2008 |
| AGI Therapeutics |
Bought by Videra |
| Agilis Biotherapeutics |
Bought by PTC Therapeutics, Aug 2018, $50M cash + $150M stock |
| Agility Clinical |
Acquired by Precision for Medicine, Sep 2017 |
| Agilix |
Acquired by Perkin-Elmer, Feb 2006 |
| Agilux Laboratories |
Acquired by Charles River, Oct 2016, $64M |
| Agouron Pharmaceuticals |
Acquired by Warner-Lambert, Jan 1999, $2.1B stock |
| Ahura Scientific |
Acquired by Thermo Fisher |
| AI Biomed |
Acquired by Medtronic, Oct 2020 |
| Aires Pharmaceuticals |
Acquired by Mast Therapeutics, Apr 2014 |
| AIT Bioscience |
Acquired by Nexelis, Jul 2020 |
| Akarna Therapeutics |
Acquired by Allergan, Sep 2016, $50M + milestones |
| AkaRx |
Acquired by Eisai, Dec 2009 |
| Akcea Therapeutics |
Spun out of Ionis Pharmaceuticals, fully reacquired Aug 2020 |
| Akers Biosciences |
Acquired by MyMD Pharmaceuticals via Reverse Merger, Nov 2020 |
| AKESOgen |
Acquired by Tempus, Dec 2019 |
| Alanex |
Acquired by Agouron, Apr 1997 |
| Alantos Pharmaceuticals |
Bought by Amgen 2007 |
| Alaris Medical |
Acquired by Cardinal Health, May 2004 |
| Alaven Pharmaceutical |
Bought by Meda, $350M, Oct 2010 |
| Alcobra Pharma |
Acquired by Arcturus, Sep 2017 via reverse merger |
| Aldagen |
Bought by Cytomedix Feb 2012 |
| Alder BioPharmaceuticals |
Acquired by Lundbeck, Oct 2019, $1.95B |
| Alere |
Acquired by Abbott, Oct 2017, $4.6B |
| Alfigen |
Acquired by Genzyme, Feb 2004 |
| Algeta |
Acquired by Bayer, Mar 2014 |
| AlgoNomics |
Acquired by Lonza, Nov 2009 |
| Algorx Pharmaceuticals |
Acquired by Corgentech in reverse merger, Dec 2005 |
| Algynomics |
Acquired by Proove Biosciences, May 2016 |
| Align Pharmaceuticals |
Acquired by Cyclacel, Oct 2007 |
| Alimetrix |
Acquired by Spectrum Solutions, Mar 2023 |
| Alios Biopharma |
Acquired by J&J Nov 2014, $1.75B |
| Alivio Therapeutics |
Fully absorbed into PureTech, Jun 2021 |
| Alize Pharma |
Acquired by Millendo Therapeutics, Dec 2017 |
| Alize Pharma II |
Acquired by Jazz Pharmaceuticals, Jun 2016, €8M + €10M milestones |
| Alkan Pharma |
Acquired by Hikma, Apr 2011, $60.5M |
| Allcyte |
Acquired by Exscientia, Jun 2021 |
| Allegro Diagnostics |
Acquired by Veracyte, late 2014 |
| Allendale Pharmaceuticals |
Acquired by Synova Healthcare, Feb 2007, $16M stock |
| Allenex |
Bought by CareDx, Apri 2016 |
| Allergan |
Acquired by AbbVie, May 2020, $63M |
| Allergy Immuno Technologies |
Acquired by rubber company, 2003 |
| Allergy Laboratories |
Likely acquired by ALK-Abello, Dec 2016 |
| Alliance Biosciences |
Acquired by WIRB-Copernicus Group, Jul 2014 |
| Alliance Contract Pharma |
Acquired by Altasciences, Feb 2020 |
| Alliance Medical Products |
Acquired by Siegfried, May 2012 |
| Alliant Pharmaceuticals |
Acquired by Sciele Pharma, Jun 2007 |
| AlliedPath |
Acquired by IRIS International, Aug 2010 |
| Allomek Therapeutics |
Acquired by Pasithea Therapeutics, Oct 2022 |
| Allon Therapeutics |
Assets acquired by Paladin Labs, Jun 2013 |
| Allos Therapeutics |
Acquired by Spectrum Pharmaceuticals Sep 2012 |
| Alltracel Pharmaceuticals |
Bought by HemCon, 2008 |
| Allylix |
Acquired by Evolva, Nov 2014, $59M stock |
| Almedica |
Acquired by Aptuit, Sep 2005 |
| Alnara Pharmaceuticals |
Bought by Eli Lilly, Jul 2010, $380M |
| Aloka |
Acquired by Hitachi Medical, Jun 2011 |
| Alpha Innotech |
Acquired by Cell Biosciences, Sep 2009 |
| Alpha-5 integrin |
Acquired by Pasithea Therapeutics, Jun 2022 |
| AlphaCore Pharma |
Bought by MedImmune, Apr 2013 |
| AlphaPharm |
Acquired by Mylan, 2007 |
| Alpharma |
Bought by King Pharmaceuticals, now part of Zoetis |
| Alphora Research |
Acquired by eurofins, Jun 2017 |
| Alpine Biomed |
Acquired by Natus, Sep 2009 |
| Alpine Biosciences |
Acquired by Oncothyreon Aug 2014, $27M in stock |
| Alsius |
Assets purchased by Zoll Medical, May 2009, $12M |
| Altair Clinical |
Bought by Accelovance, Feb 2015 |
| Alteris Therapeutics |
Bought by Celldex Oct 2005, $1.5M plus stock/milestones |
| Althea Technologies |
Acquired by Ajinomoto, Mar 2013 |
| AltheaDx |
Acquired by Castle Biosciences, Apr 2022 |
| Altiva |
Acquired by Exactech, Jan 2008 |
| Altor Bioscience |
Bought by NantCell, Aug 2017, $360M |
| Altura Medical |
Bought by Lombard Medical Aug 2015, though it was closed Aug 2013 according to Crunchbase |
| Alveolus |
Assets acquired by Merit Medical, Mar 2009 |
| Alverix |
Acquired by BD, Jan 2014 |
| Alvine Pharmaceuticals |
Assets acquired by ImmunogenX, Mar 2016 |
| Alvos Therapeutics |
Bought by Arrowhead Research, Apr 2012, $23.5M stock |
| Alydia Health |
Acquired by Organon Jun 2021; fka InPress Technologies |
| ALZA |
Bought by J&J, Jun 2001, $11.8B stock |
| AMAG Pharmaceuticals |
Acquired by Covis Pharma, Nov 2020 |
| Amalyte Pharmaceuticals |
Acquired by Kemin Jun 2009 |
| Amaryllis Nucleics |
Acquired by Active Motif, Jan 2022 |
| amaxa |
Acquired by Lonza, Jul 2008 |
| Ambest Pharmaceuticals |
Bought by Sihuan Pharmaceutical, Mar 2017, $160M |
| AMBI Pharmaceuticals |
Acquired by Neuro-Hitech, Nov 2008 |
| Ambion |
Bought by Applied Biosystems 2006 |
| Ambit Biosciences |
Bought by Daiichi Sankyo, Nov 2014 |
| Amblyotech |
Acquired by Novartis, Apr 2020 |
| AmCell |
Seems to have been subsumed into Miltenyi |
| AmCyte |
Acquired by ReNeuron, Aug 2007, $4M |
| Amdipharm |
Acquired by Concordia Healthcare, Sep 2015 |
| Amedis Pharmaceuticals |
Acquired by Takeda, Jan 2005 |
| Amedra Pharmaceuticals |
Acquired by Impax Laboratories, Mar 2015 |
| American Bionostica |
Acquired by Ott Scientific, May 2021 |
| American Peptide Company |
Acquired by Bachem, Feb 2015 |
| AMF Medical |
Acquired by Tandem Diabetes, Jan 2023 |
| Amide Pharmaceutical |
Acquired by Actavis, Jul 2005 |
| Amira Medical |
Acquired by Roche, Nov 2001 |
| Amira Pharmaceuticals |
Acquired by BMS, Jul 2011, $325M |
| Amnestix |
Acquired by SYGNIS, Jun 2008, $6M |
| Amnis |
Acquired by EMD Millipore, Aug 2011 |
| Amomed Pharma |
Acquired by AOP, Jan 2022 |
| Amorcyte |
Acquired by Neostem, Oct 2011 |
| Amorsa Therapeutics |
Acquired, 2022 |
| Amplimmune |
Bought by MedImmune Oct 2013, $225M |
| Amplyx Pharmaceuticals |
Acquired by Pfizer Apr 2021 |
| AmpTec |
Acquired by Merck KGaA, Jan 2021 |
| Amresco |
Acquired by VWR, Feb 2011 |
| Amsterdam Molecular Therapeutics |
Acquired by UniQure |
| AMUR Pharmaceuticals |
Bought by SuperGen |
| Amylin Pharmaceuticals |
Bought by BMS Aug 2012 |
| ANA Therapeutics |
Acquired by NeuroBo Pharmaceuticals, Dec 2020 |
| Anacor Pharmaceuticals |
Bought by Pfizer, Jun 2016, $5.2B |
| Anadys Pharmaceuticals |
Acquired by Roche 2011 |
| Anagnostics |
Assets acquired by CubeDx, Jul 2015 |
| Anakuria Therapeutics |
Acquired by Janssen, Feb 2022 |
| Analgesic Solutions |
Acquired by WCG, Apr 2019 |
| Analytical Bio-Chemistry Laboratories |
Acquired by EAG, Jul 2015 |
| Analytical Lab Group |
Acquired by Element, now Element Life Sciences |
| Anayaderm |
Acquired by Alexar Therapeutics, 2014 |
| Anchen |
Bought by Par Pharmaceutical |
| Anchen Pharmaceuticals |
Acquired by Par Pharmaceutical, Aug 2011 |
| Ancile Pharmaceuticals |
Acquired by Mera Pharmaceuticals, Jan 2003 |
| Ancora Pharmaceuticals |
Assets Acquired by Corden Pharm, Oct 2013 |
| Andara Life Science |
Acquired by CyberKinetics, Feb 2006 |
| Andromeda Biotech |
Acquired by Hyperion, Jun 2014 |
| Andrx Pharmaceuticals |
Acquired by Watson Pharmaceuticals, Nov 2006, $1.9B |
| Anelixis Therapeutics |
Acquired by Novus Therapeutics, Sep 2020; fka Anelixis Pharmaceuticals |
| Angioblast Systems |
Acquired by Mesoblast, May 2010 |
| Angiolink |
Acquired by Medtronic, Nov 2004 |
| AngioScore |
Acquired by Spectranetics, May 2014, $230M+ |
| AngioSense |
Acquired by MicroHeart, Sep 2001 |
| Angiosyn |
Acquired by Pfizer 2005 |
| Angstrom Medica |
Acquired by Pioneer Surgical, Oct 2007 |
| Annovation Biopharma |
Acquired by The Medicines Company, Feb 2015 |
| Annovis |
Acquired by Transgenomic, May 2001 |
| AnorMED |
Acquired by Genzyme, Oct 2006 |
| Anosys |
Acquired by Chromos Molecular Systems, Dec 2001 |
| Ansan Pharmaceuticals |
Acquired by Discovery Labs, Jul 1997 |
| Anteco Pharma |
Acquired by Attwill Vascular, Nov 2017 |
| Anterios Therapeutics |
Acquired by Allergan, Jan 2016, $90M |
| Antex Biologics |
Bought by BioPort, Jun 2003 |
| Anthrogenesis |
Acquired by Celegene, Jan 2003, $45M |
| Anvil Biosciences |
Assets acquired 2017-2018 |
| Anza Therapeutics |
Closed Feb 2009, assets bought by Aduro Biotech |
| AorTech |
Acquired RUA Medical, Mar 2020,, took name |
| Aortica |
Acquired by Terumo, Nov 2019 |
| AorTx |
Acquired by Hansen Medical, Nov 2007, $4.5M |
| Apama Medical |
Acquired by Boston Scientific, Oct 2017, $175M + $125 Milestones |
| ApaTech |
Acquired by Baxter, Mar 2010, $330M |
| apceth |
Acquired by Hitachi Chemical, Apr 2019 |
| ApcinteX |
Centessa Company |
| Apex Bioscience |
Acquired by CuraCyte, fka Strohtech |
| Apica Cardiovascular |
Acquired by Thoratec, Jul 2014 |
| Apitope |
Acquired by Wong Pharmaceuticals |
| ApoCell |
Acquired by Precision for Medicine, Jul 2019 |
| Apogent |
Acquired by Fisher, Aug 2004 |
| Apollo Biopharmaceutics |
Acquired by MitoKor, May 2001 |
| Apollo Cytokine Research |
Acquired by Symansis, Jun 2008 |
| Apoptos |
Acquired by Receptos |
| APP Pharma |
Bought by Fresenius Kabi, Jul 2008, $4.6B |
| Applied Biology |
All assets purchased by Jupiter Wellness, Jun 2022 |
| Applied Biosystems |
Bought by Thermo Fisher, Jun 2008, $6.7B |
| Applied Immune Technologies |
Bought by Adicet Bio, Jan 2016 |
| Applied Immunology |
Acquired by Precision for Medicine, May 2016 |
| Applied Molecular Evolution |
Bought by Eli Lilly, Feb 2004 |
| Applied Proteomics |
Assets bought by DiscernDx, Feb 2018, $1.85M |
| Applikon Biotechnology |
Acquired by Getinge, Jan 2020 |
| Aptalis |
Acquired by Forest Labs, Jan 2014, $2.9B |
| Aptiv Solutions |
Bought by ICON plc, May 2014 |
| Aptuit |
Bought by Evotec, Aug 2017, $300M |
| Aptus Endosystems |
Acquired by Medtronic, Jul 2015, $110M |
| Aqua Pharmaceuticals |
Acquired by Almirall, up to $400M |
| Aquapharm Biodiscovery |
Acquired by Lallemand Dec 2013 |
| Aquarius Biotechnologies |
Acquired by Matinas Biopharma, Jan 2015 |
| Aquatrove BioSciences |
Bought by SASMAR, Aug 2016 |
| AqueSys |
Acquired by Allergan, Oct 2015, $300M |
| Aquila Biopharmaceuticals |
Acquired by Antigenics, Aug 2000, $40M |
| Aquinox Pharmaceuticals |
Acquired via Reverse Merger by Neoleukin Therapeutics Aug 2019; Stopped all RD Jul 2018 |
| Aragon Pharmaceuticals |
Bought by J&J, Jun 2013, $1B |
| Aratinga Bio |
Acquired by Ixaka, Jan 2021, $54M |
| Arbor Pharmaceuticals |
Acquired by Azurity, Sep 2021 |
| ARC Medical Design |
Acquired by Olympus, Aug 2020 |
| ArcherDx |
Acquired by Invitae, Oct 2020, $1.4B; Spun out of Enzymatics after Qiagen acquired |
| Archimedes Pharma |
Acquired by ProStakan, Jul 2014, $394M |
| Arcinova |
Acquired by Quotient Sciences, Feb 2021 |
| Ardea Biosciences |
Bought by AstraZeneca, Jun 2012, $1.26B; Closed 2018 |
| Ardian |
Acquired by Medtronic, Nov 2010, $800M |
| Arena Pharmaceuticals |
Acquired by Pfizer, Dec 2021, $6.7B |
| Argene |
Acquired by bioMérieux, Jul 2011, $60M |
| Argenta Discovery |
Bought by Charles River Labs, Mar 2014 |
| Ariad Pharmaceuticals |
Acquired by Takeda, Feb 2017, $5.2B |
| Aribex |
Acquired by Danaher, Nov 2012 |
| Ariosa Diagnostics |
Bought by Roche, Dec 2014, $400M+$225M contingent |
| Aristos Pharmaceuticals |
Owned by Cornerstone Therapeutics |
| Arius Pharmaceuticals |
Acquired by BioDelivery Sciences, Aug 2004 |
| Arixa Pharmaceuticals |
Acquired by Pfizer, Oct 2020 |
| Arkis Biosciences |
Acquired by Integra LifeSciences, Jul 2019 |
| ArmaGen |
Acquired by JCR Pharmaceuticals, Apr 2020 |
| ARMO BioSciences |
Acquired by Lilly, Jul 2018, $1.6B |
| Armune Bioscience |
Acquired by Exact Sciences, Dec 2017 |
| Aronex Pharmaceuticals |
Acquired by Antigenics, Apr 2001 |
| Aros Applied Biotechnology |
Acquired by eurofins |
| Arpida |
Acquired by Evolva, Sep 2009 |
| ArQule |
Bought by Merck, Jan 2020, $2.7B |
| Array Biopharma |
Bought by Pfizer, Jul 2019, $11.4B |
| Arrayon Biotechnology |
Acquired by Endetec@Veolia, 2011 |
| Arresto Biosciences |
Bought by Gilead, Jan 2011, $225M |
| Arrevus |
Acquired by Aceragen, Nov 2021 |
| Arrow Therapeutics |
Bought by AstraZeneca, Feb 2007 |
| Arsanis Biosciences |
Acquired by X4 Pharmaceuticals via reverse merger, Mar 2019 |
| Arsia Therapeutics |
Bought by Eagle Pharmaceuticals, Nov 2016, $30M + $48M milestones |
| Artegraft |
Acquired by Lemaitre Vascular, Jun 2020, $72.5M |
| Arthrocare |
Acquired by Smith & Nephew, May 2014 |
| Arthrosurface |
Acquired by Anika Therapeutics, Feb 2020, $100M |
| Artisan Pharma |
Acquired by Asahi Kasei Pharma, Nov 2011 |
| Artu Biologicals |
Sold by Fornix Biosciences to ALK-Abello |
| Asante Solutions |
Assets acquired by Bigfoot Biomedical, May 2015 |
| Ascendance Biotechnology |
Acquired by BioIVT, Mar 2018 |
| Asentral IRB |
Acquired by Brany, Dec 2019 |
| Ash Stevens |
Acquired by Piramal, Aug 2016, $53M |
| Aspreva |
Acquired by Vifor Pharma |
| Assurex Health |
Acquired by Myriad Genetics, Sep 2016, $200M, renamed GeneSight |
| Asterand |
Bought by Stemgent, Aug 2012, Some assets sold on to ReproCELL, then company renamed Asterand Bioscience |
| Asterand Bioscience |
Bought by BioreclamationIVT, Aug 2017; Bought by Stemgent, Aug 2012 |
| Asterias Biotherapeutics |
Fully absorbed into BioTime Mar 2019; Technology acquired from Geron |
| Astero Bio |
Acquired by BioLife Solutions, Apr 2019, $8M; Bought all assets of MedCision, May 2018 |
| Asthmatx |
Bought by Boston Scientific, Sep 2010, $194M + milestones |
| Astion Pharma |
Products acquired by Cipher Pharmaceuticals, Feb 2015 |
| ASTrego Diagnostics |
Acquired by Sysmex, May 2022 |
| Astute Medical |
Acquired by bioMérieux, Apr 2018, $90M |
| Asymptote |
Acquired by GE Healthcare, Apr 2017 |
| Ataxion Therapeutics |
Bought by Clal Biotech, Mar 2017, became Luc Therapeutics |
| Athena Diagnostics |
Acquired by Fisher Diagnostics, Mar 2006 |
| Athena Neurosciences |
Acquired by Elan, 1996 |
| Atheromed |
Acquired by Volcano, May 2014, $115M |
| Atlab Pharma |
Bought by Telix Pharmaceuticals, Jan 2017 |
| Atlanta Biologicals |
Acquired by Bio-Techne, 2018 |
| Atlas Chemical Industries |
Acquired by ICI, 1972 |
| ATMI - Life Sciences |
Life Science business acquired by Pall, Feb 2014 |
| Atoll |
Acquired by Repligen, Apr 2016, $9.1M cash + stock |
| Atopix Therapeutics |
Bought by Chiesi, 2016 |
| Atreus Pharmaceuticals |
Acquired by Advanced Accelerator Applications, Jan 2015 |
| Atrin Pharmaceuticals |
Acquired by Aprea Therapeutics, May 2022 |
| Atritech |
Bought by Boston Scientific, Mar 2011, $100M + $275 milestones |
| ATS Medical |
Bought by Medtronic, Apr 2010, $370M |
| Attenua |
Acquired by CODA Biotherapeutics, Feb 2020 |
| Atugen |
Acquired by SR Pharma 2005 |
| ATXCo |
Acquired by Blade Therapeutics, Sep 2019 |
| Audentes Therapeutics |
Acquired by Astellas, Jan 2020, $3B |
| Augmenix |
Acquired by Boston Scientific, Oct 2018, $500M + $100M milestones |
| Aurelia Bioscience |
Acquired by Chernwood Molecular, Jun 2021 |
| Aurex Laboratories |
Acquired by APNAR Pharma, Jul 2022 |
| Auris Health |
Acquired by J&J, Apr 2019, $3.4B; fka Auris Surgical Robots |
| AurKa Pharma |
Acquired by Lilly, May 2018 |
| Aurora Biosciences |
Acquired by Vertex Pharmaceuticals, 2001 |
| Aushon Biosystems |
Acquired by Quanterix, Jan 2018 |
| Auspex Pharmaceuticals |
Bought by Teva Mar 2015, $3.2B |
| Auxilium Pharmaceuticals |
Acquired by Endo Oct 2014, $2.6B |
| Avalon |
Acquired by Nordson Medical, Aug 2014 |
| Avalon Pharmaceuticals |
Bought by Clinical Data |
| Avanir Pharmaceuticals |
Website down Jan 2023 - Mar 2023; Bought by Otsuka, Jan 2015, $3.5B |
| Avant Diagnostics |
Assets acquired by OncBioMune, Jun 2020 |
| Avecia |
Bought by Nitto Denko |
| Avedro |
Acquired by Glaukos, Nov 2019 |
| Avema Pharma |
Bought by PL Developments |
| Averitas Pharma |
Acquired by Grunenthal Nov 2018 |
| Aveva Drug Delivery Systems |
Acquired by DifGen Pharmaceuticals, Apr 2023; Acquired by Apotex, Mar 2012 |
| AveXis |
Acquired by Novartis, Apr 2018, $8.7B |
| Avia Biosystems |
Acquired by Unchained Labs, Jun 2015 |
| Avid Radiopharmaceuticals |
Bought by Lilly, Nov 2010, $800M |
| Avida Biomed |
Acquired by Agilent, Jan 2023 |
| Avidea Technologies |
Acquired by Vaccitech, Dec 2021 |
| Avidex |
Bought by MediGene, Aug 2006, $62.4M |
| Avidia |
Bought by Amgen 2006, Sep 2006, $380M |
| Avigen |
Bought by Medicinova, Dec 2009, $37M |
| Avila Therapeutics |
Bought by Celgene, Jan 2012, $350M |
| Aviragen Therapeutics |
Acquired by reverse merger by Vaxart, Jan 2018; fka Biota Pharmaceuticals |
| Aviron |
Acquired by Medimmune, Dec 2001, $1.5B |
| Avista Pharma Solutions |
Bought by Cambrex, Jan 2019, $252M; Formed from the CMC business of Array BioPharma and contract services business of Scynexis |
| Avizorex Pharma |
Acquired by Aerie Pharmaceuticals, Nov 2019; aka AVX Pharma |
| Avomeen |
Acquired by Element, Mar 2021 |
| Avrio Biopharma |
Company was consolidated into Irvine Pharmaceutical Services |
| Axela |
Acquired by Angle plc, Oct 2017, $6M |
| Axenis |
Acquired by genOway, Sep 2018 |
| Axio Research |
Acquired by Cytel, Jun 2019 |
| AxioMx |
Acquired by Abcam, Nov 2015, $20M + $25 milestones |
| Axsun |
Acquired by Excelitas Technologies Jan 2019; Spun back out by Philips, Oct 2015; Acquired by Volcano Jan 2009 |
| Axys Pharmaceuticals |
Acquired by Celera, Nov 2001, $174M |
| Azanta |
Acquired by Norgine, Mar 2020 |
| Azur Pharma |
Acquired by Jazz Pharmaceuticals, Sep 2011 |
| Bacchus Vascular |
Bought by Covidien, Jun 2009, undisclosed terms |
| Baergic Bio |
Acquired by Avenue Therapeutics, Nov 2022 |
| Baliopharm AG |
Acquired by Promethera Biosciences, Apr 2018 |
| Baliopharm GmbH |
Bought by Alvotech, May 2016 |
| Bamboo Therapeutics |
Bought by Pfizer, Jul 2016, $150M + milestones |
| Banner Pharmacaps |
Acquired by Patheon, Dec 2012, Renamed Banner Life Sciences |
| Barofold |
Assets Acquired by Pressure Biosciences, Dec 2017 |
| Barr Pharmaceuticals |
Acquired by Teva, Jul 2008, $7.46B |
| Barrier Therapeutics |
Bought by Stiefel |
| Barrx Medical |
Acquired by Covidien, Nov 2011, $325M |
| Base Genomics |
Acquired by Exact Sciences, Oct 2020 |
| BaseHealth |
Acquired by Genalyte, Apr 2020 |
| Bausch & Lomb |
Acquired by Valeant, rebranded as Bausch Health |
| Baxa |
Acquired by Baxter, Nov 2011, $380M |
| Baxalta |
Bought by Shire, $32B, Jun 2016 |
| Bay Bioanalytical |
Acquired by Pacific BioLabs |
| Bayhill Therapeutics |
Wound Down and Assets acquired by new-incarnation of Tolerion |
| Bayon Therapeutics |
Acquired by EyeGate Pharmaceuticals, Oct 2021 |
| Bazell Pharma |
Acquired by Amzell, Mar 2021 |
| Beacon Discovery Inc |
Acquired by Eurofins Scientfiic, Feb 2021; Spun out of Arena Pharmaceuticals, Sep 2016 |
| Beardsworth |
Bought by TFS International 2013 |
| Beckley Canopy Therapeutics |
Acquired by Canopy Growth, Oct 2019 |
| Beckman Coulter Genomics |
Bought by Genewiz, Dec 2015 |
| Bellwether Bio |
Acquired by Guardant Health, Apr 2019, $10M + $20M milestones |
| Benchmark Biolabs |
Parent acquired by Huvepharma, Jan 2018 |
| Bend Research |
Acquired by Capsugel, Sep 2013 |
| BeneChill |
Assets purchase by BrainCool, Oct 2016 |
| BeneVir Biopharm |
Acquired by J&J, May 2018, $140M + $900M milestones |
| Benten BioServices |
Acquired by Deltagen, Dec 2009 |
| Bentley Pharmaceuticals |
Bought by Teva, Mar 2008, $360M |
| Benvenue Medical |
Assets acquired by Spinal Elements, Dec 2020 |
| Beogenomics |
Acquired by APIS Assay Technologies, Sep 2020 |
| Berg |
Acquired, Jan 2023 |
| Bertek |
Acquired by Mylan, Apr 1993, $39M |
| Beryllium |
Acquired by UCB Pharma, Jun 2017 |
| Bespak |
Acquired by Recipharm, 2020 |
| BetaLogics |
Absorbed by ViaCyte, Feb 2016 |
| Bethyl Laboratories |
Acquired by Fortis Life Sciences, Mar 2021 |
| Bexel Pharmaceuticals |
Bought by Orchid Pharma, Aug 2006, $3M |
| BHV Pharma |
Acquired by Avolynt, Mar 2016 |
| Biacore |
Acquired by GE, Jun 2006, $390M |
| Bikam |
Acquired by Shire, Aug 2015, $92M |
| Bina Technologies |
Acquired by Roche, Dec 2014 |
| Binax |
Acquired by Alere, Feb 2005, $9M |
| Bio Processing |
Bought by Bio-rad |
| Bio-Concept Laboratories |
Acquired by Pace Analytical, Dec 2020 |
| BioAnalytix |
Acquired by Protagen Protein Services, Apr 2019 |
| BioArra |
Bought by VWR Nov 2016 |
| BioAxoneTherapeutic |
Founded 2000, all assets acquired by BioAxone Biosciences |
| Biobase |
Bought by Qiagen, May 2014 |
| BioBehavioral Diagnostics Company |
Assets acquired by Pearson, Aug 2013 |
| Bioceros |
Bought by Epirus Biopharmaceuticals, Sep 2015, $14M |
| Biochrom GmbH |
Bought by Millipore, Nov 2012 |
| BioCision |
Acquired by Brooks, Nov 2016 |
| BioDelivery Sciences International |
Acquired by Collegium Pharmaceuticals, Mar 2022, $604M |
| Bioelectron |
Assets bought by PTC Therapeutics; fka Edison Pharmaceuticals |
| BioElectron Technology |
Assets Acquired by PTC Therapeutics, Oct 2019 |
| Bioenvision |
Acquired by Genzyme, Oct 2007, $345M |
| Biofocus |
Bought by Charles River Labs, Mar 2014, $179M |
| Biogazelle |
Acquired by CellCarta, Dec 2021 |
| BioHelix |
Acquired by Quidel, $10+milestones, May 2013 |
| Bioject |
Assets acquired by Inovio, Mar 2016, $5.5M |
| Biolipox |
Bought by Orexo, €94M, Oct 2007 |
| Biological Industries |
Acquired by Sartorius, Dec 2019, $50M |
| Biologics Process Development |
Acquired by ViroPro, 2010 |
| BioLogo |
Acquired by Nordic MUbio, Mar 2018 |
| Biomatrica |
Acquired by Exact Sciences, Oct 2018 |
| BioMedical Enterprises |
Bought by DePuy Synthes, May 2016 |
| Biomedical Systems |
Acquired by ERT, Sep 2017 |
| Biomet |
Bought by Zimmer, Apr 2014, $13.4B - combined company renamed Zimmer Biomet |
| Biomeva Manufacturing |
Acquired by Asahi Glass, Nov 2016; Now part of AGC Biologics |
| BioMimetic |
Acquired by Wright Medical, Mar 2013, $190M cash + $190M milestones |
| Biomimetic Therapeutics |
Acquired by Wright Medical group Apr 2013 |
| Bion Enterprises |
Acquired by MBL International, 2008 |
| Bioniche Pharma |
Acquired by Mylan, Sep 2010, $550M |
| Bionix Implants |
Bought by CONMED, Mar 2003 |
| Bioniz Therapeutics |
Acquired by Equillium, Feb 2022, $329M |
| Bionostics |
Bought by Techne, Jun 2013 $104M |
| BioNovion |
Bought by Aduro Biotech, Sep 2015, $32.5M |
| BionX Medical |
Acquired by Ottobock |
| Bioo Scientific |
Acquired by Perkin Elmer, Aug 2016 |
| BioPharmX |
Acquired via Reverse Merger by Timber Pharmaceuticals, May 2020 |
| BioProcess Technology Consultants |
Acquired by BDO USA, Apr 2019 |
| Bioprocessing Inc. |
Bought by Bio-Rad |
| Biopta |
Acquired by ReproCELL, combined with Reinnervate to become ReproCELL Europe, Jul 2016 |
| Biopure |
Assets bought by OPK Biotech, Aug 2009 |
| Bioren |
Acquired by Pfizer, Sep 2005 |
| BioRexis |
Acquired by Pfizer, Feb 2007 |
| BioScreen Testing Services |
Acquired by ALS Group USA, Feb 2019 |
| Bioseek |
Bought by Asterand Nov 2009, Sold to DiscoveRx Nov 2012 |
| Bioserve |
Acquired by ReproCell, 2014 |
| BioSolutia |
Acquired by CareMetx, Oct 2018 |
| BioStorage Technologies |
Acquired by Brooks Life Sciences, Nov 2015 |
| BioSyntech |
Bought by Piramal |
| Biotectix |
Acquired by Heraeus Medical Components, Aug 2017 |
| Biotek |
Acquired by Agilent, Aug 2019 |
| Biotel |
Acquired by CardioNet, 2010 |
| BioTelemetry |
Acquired by Philips, Feb 2021; fka CardioNet |
| Biotest Labs |
Acquired by/Merged with Steris |
| Biothera Pharmaceuticals |
Acquired by Hibercell, Jul 2020 |
| bioTheranostics |
Acquired by Hologic, Feb 2021, $230M; bought by bioMérieux 2008, spun out again Jan 2016 |
| Biotie Therapies |
Bought by Acorda Therapeutics, Jan 2016, $363M |
| Biotronic |
Bought by NuVasive, Jul 2016, $98M |
| BioTrove |
Acquired by Life Technologies, Dec 2009 |
| Bioverativ |
Acquired by Sanofi, Jan 2018, $11.6B; Biogen's spinout hemophilia group |
| Biovertis |
Acquired by Deinove, May 2018 |
| BioVex |
Bought by Amgen, Jan 2011, $425M + $575M milestones |
| Bioxalis |
Bought by Procyon Biopharma, Jun 2005, $3.5M |
| BioXell |
Acquired by Cosmo Pharmaceuticals, Nov 2009 |
| Bipar Sciences |
Bought by Sanofi-Aventis, Apr 2009, $500M |
| Biscayne Neurotherapeutics |
Acquired by Supernus, Oct 2018, $15M + $168M milestones |
| Bitome |
Acquired by Ginkgo Bioworks, Jun 2022 |
| BlackThorn Therapeutics |
Acquired by Neumora, Oct 2021 |
| Blockade Medical |
Acquired by BALT, Sep 2016 |
| Blu Pharmaceuticals |
Acquired by PuraCap, Mar 2016 |
| Blue Sky Bioservices |
Acquired by LakePharm Mar 2016 |
| Blue Stream Laboratories |
Acquired by Charles River, Jun 2016 |
| Blue Stream Labs |
Acquired by Charles River Labs, Jun 2016 |
| Blueshift Biotechnologies |
Acquired by MDS Analytical, Jun 2008, $13M |
| BN-ImmunoTherapeutics |
Absorbed into Bavarian Nordic, 2010? |
| Boca Pharmacal |
Bought by Qualitest |
| Boehringer Ingelheim Vetmedica |
Acquired by Elanco, Oct 2016, $885M |
| Boehringer Mannheim |
Bought by Roche, May 1997, $11B |
| Bolder Surgical |
Acquired by Hologic, Nov 2021, $160M |
| Bonti |
Bought by Allergan, Sep 2018, $195M |
| Boston Biochem |
Acquired by Techne, Apr 2011 |
| Boston Biomedical |
Renamed Sumitomo Dainippon Pharma Oncology, Jun 2020; Bought by Dainippon Sumitomo Pharma, Feb 2012, $200M plus milestones up to $2.4B |
| Boulder Diagnostics |
Assets purchased by Oxford Immunotec, Aug 2014 |
| Brabant Pharma |
Acquired by Zogenix, Oct 2014, $20M cash, $15M stock |
| Brainbits |
Acquired by Transnetyx, Feb 2021 |
| Brains On-Line |
Acquired by Charles River, Aug 2017 |
| Braintree Labs |
Bought by Sebela Pharmaceuticals, May 2018 |
| Brainvectis |
Acquired by AskBio, Apr 2020 |
| Brammer Bio |
Bought by Thermo Fisher, May 2019, $1.7B |
| Brandwood Biomedical |
Acquired by PharmaLex |
| Breath Therapeutics |
Bought by Zambon, Jul 2019, $160M + $405 Milestones |
| Breathe Technologies |
Acquired by Hillrom, Aug 2019, $130M |
| Brecon Pharmaceutical |
Acquired by AmerisourceBergen Mar 2006 $28M, Merged with Anderson Packaging Jun 2012, Acquired by Frazier Apr 2013 and merged with Packaging Coordinators Inc. (Frazier) |
| Breethe |
Acquired by Abiomed, Apr 2020 |
| BRI Biopharmaceutical Research |
Acquired by Frontage, Dec 2019 |
| Bridge Design |
Acquired by Ximedica, Aug 2015 |
| Bridgehead International |
Bought by Gfk, Mar 2012 |
| BrightWater Medical |
Acquired by Merit Medical, Sep 2019, $50M |
| Brivant Medical Engineering |
Bought by Lake Region Medical, Aug 2009 |
| Brogan Pharma |
Acquired by IMS Health, 2010 |
| BSN Medical |
Acquired by Essity, Apr 2017 |
| BTG plc |
Acquired by Boston Scientific, Aug 2019, $4.3B |
| C.R. Bard |
Acquired by BD, Dec 2017, $24B |
| C1 Consulting |
Acquired by Charles River, Jan 2017 |
| C2 Therapeutics |
Acquired by Pentax Medical, Jan 2017 |
| C3 Research Associates |
Acquired by Avance Clinical, Sep 2022 |
| Cabrellis Pharmaceuticals |
Acquired by Pharmion, Nov 2006 |
| Cadence Pharmaceuticals |
Acquired by Mallinckrodt, Mar 2014, $1.4B |
| Cadent Therapeutics |
Acquired by Novartis, Dec 2020, $210M + $560M milestones; fka Luc Therapeutics |
| Calibra Medical |
Acquired by JNJ 2012 |
| California Peptide Research |
Acquired by Echelon Biosciences, Apr 2014 |
| California Stem Cell |
Bought by NeoStem, renamed NeoStem Oncology May 2014 |
| CALiMMUNE |
Acquired by CSL Behring, Aug 2017 |
| Caliper Life Sciences |
Bought by Perkin Elmer, Sep 2011, $600M |
| Calistoga Pharmaceuticals |
Bought by Gilead, Feb 2011, $375M + $125Milestones |
| Calixa Therapeutics |
Acquired by Cubist, Dec 2009, $92.5M + $310 milestones |
| CallistoGen |
Assets acquired by The Genetics Company, Mar 2003 |
| Calporta Therapeutics |
Acquired by Merck, Nov 2019, $576M |
| Calvert Laboratories |
Acquired by Altasciences, May 2021 |
| Calydon |
Acquired by Cell Genesys Aug 2001, $17.4M stock |
| Calypso Medical Technologies |
Acquired by Varian Medical Systems, Sep 2011, $10M |
| Camargo Pharmaceutical Services |
Acquired by Premier Research, May 2021 |
| Cambridge Biomedical |
Acquired by Bioagilytix, Nov 2019 |
| Cambridge Biotechnology |
Acquired by Biovitrum, Mar 2005 |
| Cambridge Cancer Genomics |
|
| Cancer Prevention Pharmaceuticals |
Acquired by Panbela Therapeutics, Jun 2022 |
| Cancervax |
Acquired by Micromet, May 2006 |
| Cangene |
Acquired by Emergent Biosolutions, Dec 2013, $222M |
| CAPP Medical |
Acquired by Roche, Apr 2015 |
| caprotec bioanalytics |
Company or Technology Acquired by Charles River |
| Capsugel |
Bought by Lonza, Dec 2016, $5.5B |
| Captozyme |
Acquired by Arrant Bio, Nov 2019 |
| Capua BioServices |
Acquired by Olon, Jan 2019 |
| Caraco Pharmaceutical Labs |
Bought by Sun Pharma |
| Cardiac Science |
Acquired by Zoll, Aug 2019 |
| CardiAQ Valve Technologies |
Acquired by Edwards Life Sciences, Jul 2015, $350M + $50M milestones |
| Cardiogen Sciences |
Acquired by Audentes Therapeutics, Sep 2015 |
| Cardioinsight Technologies |
Acquired by Medtronic, Jul 2015 |
| Cardiokine |
Acquired by Cornerstone Therapeutics 2011 |
| CardioLabs |
Acquired by AliveCor, Jun 2021 |
| CardioMEMS |
Acquired by St. Jude Medical, Jun 2015, $455M |
| CardioPep Pharma |
Acquired by and converted to Cardiorentis |
| CardioProlific |
Bought by Philips, Jun 2017 |
| Cardiovalve |
Acquired by Venus Medtech, Dec 2021 |
| Cardioxyl Therapeutics |
Bought by BMS, Nov 2015, $300M |
| Cardiva Medical |
Acquired by Haemonetics, Jan 2021, $510M |
| Carefusion |
Bought by BD, Mar 2015, $12.2B; Spun out of Cardinal Health Sep 2009 |
| Carmel Biosciences |
Acquired by Nutriband, Sep 2018, $2.7M |
| Carmenta Bio |
Acquired by Progenity, Apr 2015 |
| Cartana |
Bought by 10X Genomics, Oct 2020 |
| Cartiva |
Acquired by Stryker as part of Wirght Medical, Nov 2019 |
| Cascadian Therapeutics |
Bought by Seattle Genetics, Feb 2018, $614m stock |
| Catalytica Pharmaceuticals |
Acquired by DSM |
| Catherex |
Spun out of Medigene, sold to Amgen, Dec 2015, $10.5M |
| CATLab - Accredited Calibration Laboratories |
Acquired by Trescal, Jan 2022 |
| cCAM Biotherapeutics |
Acquired by Merck, Aug 2015, $605M |
| CDD |
Acquired by Biofocus, Jun 2001 |
| Cedarburg Hauser Pharmaceuticals |
Acquired by AMRI, Mar 2014 |
| CeeTox |
Acquired by Cyprotex, Jan 2014 |
| Ceiba Solutions |
Bought by Perkin-Elmer, Mar 2015 |
| Celator Pharmaceuticals |
Bought by Jazz Pharmaceuticals, Jul 2016, $1.5B |
| Celenex |
Bought by Amicus Therapeutics, Sep 2018, $100M |
| Celera |
Acquired by Quest Diagnostics, Mar 2011, $671M |
| Celgene |
Bought by BMS, Nov 2019, $74B |
| Cell Culture Service |
Acquired by Evotec, Jan 2013 |
| Cell Design Labs |
Acquired by Gilead, Dec 2017, up to $567M |
| Cell Matrix |
Acquired by Cancervax |
| Cell Pathways |
Acquired by OSI Pharmaceuticals, Feb 2003, $32M |
| Cell Targeting Inc |
Bought by Biotime |
| CellAct Pharma |
Tech acquired by Mundipharma, 2017 |
| Cellartis |
Acquired by Takara Bio Jul 2014 |
| CellASIC |
Bought by Millipore, May 2012 |
| Cellective Therapeutics |
Acquired by MedImmune 2005, Up to $175M |
| Celleration |
Acquired by Alliqua Biomedical, Jun 2015, $30.4M |
| Cellero |
Acquired by Charles River, Aug 2020, $38M; fka Astarte Biologics; Merged with Key Biologics, Aug 2018 |
| Cellestis |
Acquired by Qiagen Aug 2011 |
| CellforCure |
Acquired by Novartis, Feb 2019 |
| Cellgate |
Acquired by ProGen, Feb 2008, $2.5M |
| CellRight Technologies |
Acquired by Tissue Regnix, Aug 2017 |
| Celltech |
Acquired by UCB, May 2004, $2.7B |
| Cellular Research |
Acquired by BD, Aug 2015 |
| CellzDirect |
Acquired by Life Technologies, Jan 2008 |
| Cellzome |
Acquired by GSK Mar 2012 |
| Celmed BioSciences |
Acquired by Kiadis Pharma, Dec 2006 |
| Celsee Diagnostics |
Acquired by Bio-Rad, Apr 2020 |
| Celtrix Pharmaceuticals |
Acquired by Insmed in reverse merger, May 2000 |
| Celula |
Acquired by NeoSeq |
| Cenetron Diagnostics |
Acquired by Versiti Blood Center, Jul 2019 |
| Censa Pharmaceuticals |
Acquired by PTC Therapeutics, Jun 2020 |
| CenterVue |
Merged into iCare, Apr 2020 |
| Cephalogics |
Assets acquired by Invisio Medical, Feb 2018 |
| Cephalon |
Acquired by Teva, Oct 2011, $6.8B |
| Cephea Valve Technologies |
Acquired by Abbott, Jan 2019 |
| Ceptaris Therapeutics |
Bought by Actelion, Sep 2013, $250M |
| Ception |
Bought by Cephalon, Jan 2009, $250M |
| Ception Therapeutics |
Acquired by Cephalon, 2010 |
| Cerebrus CNS Drug Discovery |
Acquired by Vernalis |
| Ceregene |
Acquired by Sangamo, Aug 2013 |
| Cerep |
Acquired by eurofins, Dec 2012 |
| Cerexa |
Acquired by Forest Labs Dec 2006 |
| Cernostics |
Acquired by Castle Bioscience, Dec 2021, up to $30M + $50M Milestones |
| Ceros Pharmaceuticals |
Acquired by Auxeris Therapeutics, Jan 2004 |
| CerSci Therapeutics |
Acquired by Acadia Pharmaceutical, Aug 2020, $52.5M stock |
| Cerulean Pharma |
Bought by Dare Bioscience, Mar 2017 |
| Ceterix Orthopaedics |
Acquired by Smith & Nephew, Jan 2019, $50M + $55M Milestones |
| CGI Pharmaceuticals |
Bought by Gilead 2010 |
| Chamow & Associates |
Acquired by Alira Health, Jan 2021 |
| ChanTest |
Acquired by Charles River, Oct 2014, $52M + $2M milestones |
| Chase Pharmaceuticals |
Acquired by Allergan, Nov 2016, $125M |
| Chatham Therapeutics |
Acquired by Baxter, Apr 2014, $70M+ |
| Chattem |
Bought by Sanofi, Dec 2009, $1.9B |
| Checkmate Pharmaceuticals |
Acquired by Regeneron, May 2022, $250M |
| Cheetah Medical |
Bought by Baxter, Oct 2019, $190M + $40 Milestones |
| Chelsea Therapeutics |
Acquired by Lundbeck, Jun 2014, up to $658M |
| Chem-Tech |
Bought by Neogen, Jan 2014 |
| ChemGen |
Bought by Elanco (Lilly) Jan 2012 |
| ChemGenex |
Bought by Cephalon Mar 2011 |
| Chemgenics Pharmaceuticals |
Acquired by Millennium Pharmaceuticals, Feb 1997, $89M |
| Chemic Laboratories |
Acquired by Solvias, Jun 2021 |
| Chemir Analytical Services |
Acquired by EAG, 2011 |
| ChemoCentryx |
Acquired by Amgen, $3.7B, Oct 2022 |
| Cherokee Pharmaceuticals |
Bought by Merck Aug 2010? |
| Chester Valley Pharmaceuticals |
Bought by Graceway |
| Chiasma Pharma |
Acquired by Amryt Pharma, Aug 2021 |
| Chikujee Therapeutics |
Acquired by Investors, Website Gone, CEO gone Aug 2016 |
| Chiltern |
Acquired by LabCorp, $1.2B, Jul 2017 |
| Chiron |
Bought by Novartis |
| Chiron Behring Vaccines |
Bought by Bharat Biotech, Feb 2019 |
| ChromoTek |
Acquired by Proteintech, Oct 2020 |
| Cianna Medical |
Acquired by Merit Medical, Nov 2018, $200M |
| Ciba Vision |
Bought by Alcon, bought by Novartis |
| Ciclofilin Pharmaceuticals |
Acquired by ContraVir, Jun 2016, $17M + stock |
| Ciel Medical |
Acquired by Vyaire Medical, Apr 2017 |
| CIMA Labs |
Acquired by Teva, May 2011 |
| CIMEX Pharma |
Acquired by Acino, 2004 |
| Cinfa Biotech |
Acquired by Mundipharma, Oct 2018 |
| Circe Biomedical |
Acquired by ICN Pharmaceuticals, Oct 2002 |
| Circularis |
Acquired by Ginkgo Bioworks, Oct 2022 |
| CircuLite |
Bought by HeartWare, Dec 2013, $30M+$320Milestones |
| Circulomics |
Acquired by Pacific Biosciences, Aug 2021 |
| Cirrus Pharmaceuticals |
Acquired by Kemwell, Jul 2013 |
| Cisbio |
Acquired by PerkinElmer, Apr 2019 |
| Cistron Biotechnology |
Acquired by Celltech Group, Nov 2000 |
| CiToxLAB |
Acquired by Charles River, Apr 2019, €448M |
| CITrials |
Acquired by Cenexel Clinical Research, Mar 2021 |
| Citron Pharma |
Assets acquired by Rising Pharmaceuticals, Dec 2016 |
| CiVentiChem |
Acquired by Sterling Pharma |
| Civitas Therapeutics |
Acquired by Acorda, Sep 2014, $525M. Formerly an Alkermes spinout. |
| Claret Medical |
Acquired by Boston Scientific, Jul 2018, $220M + milestone |
| Clarient |
Acquired from GE Healthcare by NeoGenomics, Oct 2015, $265M |
| Claris Lifesciences |
Bought by Baxter, Jul 2017 |
| Claritas Pharmaceuticals |
Website down Jul 2022 - Mar 2023; fka Kalytera; Acquiring Salzman Group Feb 2021 |
| Claros Diagnostics |
Acquired by Opko Health, Oct 2011 |
| CLCbio |
Acquired by Qiagen, 2013 |
| Clear Genetics |
Being Acquired by Invitae, Nov 2019, $50M |
| Clementia Pharmaceuticals |
Bought by Ipsen, Apr 2019, $1.31B |
| Cleveland Biolabs |
Acquired by Cytocom via Reverse Merger, Oct 2020 |
| ClinArt MENA |
Acquired by CTI Facts, Sep 2020 |
| Clinical Data |
Bought by Forest Labs Feb 2011 |
| Clinical Network Services (Cns) |
Acquired by Novotech |
| Clinical Research Advantage |
Bought by Radiant Research, Nov 2012 |
| Clinical Research Laboratories |
Acquired by eurofins, Sep 2018 |
| ClinicalRM |
Acquired by Icon plc, Sep 2016; aka Clinical Resource Management |
| Clinlogix |
Bought by NAMSA, Aug 2021 |
| Clintec |
Acquired by IQVIA, Dec 2018 |
| Clintrax Global |
Acquired by WCG, Mar 2016 |
| Co-Formulate |
Acquired by Quotient Clinical, Feb 2017 |
| Coastal Genomics |
Acquired by Yourgene, Aug 2020, up to $5.5M + $8M milestones |
| Cobra Biologics |
Bought by Cognate BioServices, Nov 2019 |
| Codman Neurosurgery |
Bought by Integra Life Sciences, Oct 2017, $1.045B |
| Cody Laboratories |
Bought by Lannett, 2007 |
| Cogentix Medical |
Acquired by Laborie, Apr 2018 |
| Cognate Bioservices |
Acquired by Charles River, Mar 2021; $875M |
| Cognis Corp |
Acquired by BASF 2010 |
| Coldstream Laboratories |
Bought by Piramal |
| Coley Pharma |
Acquired by Pfizer |
| CollaGenex |
Acquired by Galderma, Feb 2008, $420M |
| Collateral Therapeutics |
Acquired by Schering, Mar 2002, $140M stock |
| CoLucid Pharmaceuticals |
Acquired by Lilly, Jan 2017, $960M |
| Combangio |
Acquired by Kala Pharmaceuticals, Nov 2021 |
| CombiMatrix |
Acquired by Invitae, Nov 2017 |
| Combinati |
Acquired by Thermo Fisher, Oct 2021 |
| Comet Therapeutics |
Acquired by VectIvBio, Aug 2021 |
| Companion Medical |
Acquired by Medtronic, Aug 2020 |
| Compendia Bioscience |
Acquired by Life Technologies, Oct 2012 |
| Comprehend Systems |
Acquired by Saama Technologies, Aug 2019 |
| Conatus Pharmaceuticals |
Acquired by Histogen via Reverse Merger, Jun 2020 |
| Concentric Medical |
Acquired by Stryker, Oct 2011 |
| Concept Inc |
Bought by BMS, 1990; sold to CONMED Dec 1997 |
| Conceptus |
Bought by Bayer Apr 2013 |
| Concord Biosciences |
Acquired by Frontage Labs, Apr 2018 |
| Concortis Biosystems |
Acquired by Sorrento Therapeutics, Dec 2013 |
| Conexio Genomics |
Acquired by Illumina, Jan 2016 |
| Confab Laboratories |
Bought by Mylan, Jun 2016 |
| Confluence Life Sciences |
Acquired by Aclaris Therapeutics, Aug 2017, $10M cash + $10M shares |
| Conforma Therapeutics |
Acquired by Biogen Idec, May 2006, $150M stock + $00M Milestones |
| Conor Medsystems |
Acquired by Johnson & Johnson, Nov 2006, $1.4B |
| Consort Medical |
Acquired by Recipharm, Apr 2020 |
| Constellation Pharmaceuticals |
Acquired by MorphpSys, Jul 2021 |
| Contura |
Acquired by Axonics, Feb 2021, $200M |
| Conventus Orthopaedics |
Acquired Flower Orthopedics, May 2020, took name |
| Convergence Pharmaceuticals |
Bought by Biogen Idec, Jan 2015, $200M +$475 Milestones |
| Cook Pharmica |
Bought by Catalent, Oct 2017 |
| CoreLab Partners |
Bought by JLL then merged with Bioclinica, 2013 |
| CorePharma |
Acquired by Impax Laboratories, Mar 2015 |
| Corevalve |
Acquired by Medtronic, Feb 2009, $700M + milestones |
| Corindus Vascular Robotics |
Acquired by Siemens Healthineers, Oct 2019 |
| Corinthian Ophthalmic |
Assets bought by Eyenovia, Oct 2014 |
| Corixa |
Bought by GSK, 2005; closed 2006 |
| Corlieve Therapeutics |
Acquired by uniQure, Jun 2021, $55M + $240M milestones |
| CorMatrix Cardiovascular |
Bought by Aziyo Biologics, May 2017 |
| Cormorant Pharmaceuticals |
Acquired by BMS, Jul 2016, $95M + $425M milestones |
| Cornerstone Therapeutics |
Acquired by Chiesi Farmaceutici, Feb 2014 |
| CORPAK MedSystems |
Acquired by Avanos Medical, Apr 2016, $174M |
| Correlogic |
Assets bought by Vermillion 2011 |
| Correvio |
Acquired by Advanz Pharma, May 2020, $76M |
| Correvio (1) |
Acquired by Cardiome, Nov 2013, name resurrected and taken by Cardiome, May 2018 |
| Corthera |
Acquired by Novartis 2010 |
| Corticrine |
Bought by Actinogen, Aug 2014, $5.75M |
| Corus Pharma |
Bought by Gilead, Aug 2006 |
| Corvas International |
Acquired by Dendreon Pharmaceuticals, Nov 2003 |
| Corvidia Therapeutics |
Acquired by Novo Nordisk, Aug 2020, $725M |
| Cosman Medical |
Bought by Boston Scientific, Jul 2016 |
| CoStim Pharmaceuticals |
Acquired by Novartis, Feb 2014 |
| Coté Orphan |
Acquired by Quintiles, Jun 2017 |
| Cougar Biotechnology |
Bought by J&J |
| Coulter Pharmaceutical |
Bought by Corixa, Oct 2000 |
| Counsyl |
Acquired by Myriad Genetics, Aug 2018 |
| County Line Pharmaceuticals |
Acquired by Alvogen, Mar 2016, $300M |
| Courier Therapeutics |
Acquired by Valo Health, Jul 2021 |
| Covagen |
Acquired by Janssen Pharmaceutical, Aug 2014 |
| Covance |
Acquired by LabCorp, Feb 2015, $5.7B |
| Covidien |
Bought by Medtronic, Jan 2015, $42.9B |
| CovX Research |
Bought by Pfizer |
| CPEX Pharmaceuticals |
Bought by FCB I Holdings, Apr 2011. Not sure what they did with the company/assets. Originally was a spinout from Bentley Pharmaceuticals when it was acquired by Teva in 2008 |
| Creabilis |
Acquired by Sienna Biopharmaceuticals, Dec 2016, up to $150M |
| Crealta Pharmaceuticals |
Acquired by Horizon Pharma, Dec 2015, $510M |
| Creganna Medical |
Acquired by TE Connectivity, Apr 2016, $895M |
| Creoptix |
Acquired by Malvern Panalytical, Jan 2022 |
| Crescendo Bioscience |
Bought by Myriad Genetics, Mar 2014 |
| CRISI Medical Systems |
Acquired by BD, Mar 2015 |
| CrossRoads Extremity Systems |
Acquired by DePuy, Feb 2022 |
| Crucell |
Acquired by J&J, Mar 2011, $2.3B |
| Crux Biomedical |
Acquired by Volcano, Dec 2012, $36M |
| CryoVascular |
Bought by Boston Scientific, 2005 |
| Crystal Bioscience |
Acquired by Ligand Pharmaceuticals, Oct 2017, $25M |
| Crystal Laboratory |
Acquired by ALK-Abello, Dec 2016 |
| Crystax Pharmaceuticals |
Acquired by Oryzon Genomics, Mar 2009 |
| Cryterion Medical |
Boston Scientific acquired remaining 65% stake, Jul 2018, $202M |
| Cubist Pharmaceuticals |
Bought by Merck Jan 2015 |
| Curacyte Discovery |
Acquired by The Medicines Company, Aug 2008 |
| CuraGen |
Bought by Celldex 2009, $94.5M |
| Curative Medical |
Acquired by ResMed, Oct 2015 |
| CureDM |
Acquired by Boston Scientific, Feb 2018 |
| Curiosity Diagnostics |
Acquired by Bio-Rad, Aug 2022, $100M + $70M Milestones |
| CURNA |
Acquired by Opko Health, Feb 2011 |
| Curoverse |
Bought by Veritas Genetics, Aug 2017 |
| CustomArray |
Acquired by GenScript, Dec 2017 |
| Custopharm |
Acquired by Hikma, Apr 2022, $375M + $50M milestones |
| Cutanea Life Sciences |
Acquired by Biofrontera, Mar 2019 |
| CV Therapeutics |
Acquired by Gilead Apr 2009, $1.4B |
| CXR Biosciences |
Acquired by Concept Life Sciences, Aug 2015 |
| CyberHeart |
Acquired by Varian, May 2019 |
| CyDex Pharmaceuticals |
Acquired by Ligand Jan 2011 |
| Cylex |
Bought by Viracor-IBT Feb 2013 |
| CymoGen Dx |
Acquired by Biocare Medical, Mar 2015 |
| Cynapsus Therapeutics |
Acquired by Sunovion, Oct 2016, $635M |
| Cypher Genomics |
Acquired by Human Longevity, Dec 2015 |
| Cypress Bioscience |
Acquired by Royalty Pharma |
| Cypress Pharmaceuticals |
Acquired by Pernix |
| Cyprotex |
Acquired by Evotec, Dec 2016, £ 55.7M |
| Cytapex Bioinformatics |
Acquired by Insightful Science, May 2020 |
| CytoBioscience |
Acquired in Reverse Merger, entity renamed Inventa Biotech |
| Cytocell |
Acquired by Oxford Gene Technology, Mar 2014 |
| Cytochroma |
Acquired by Opko Health |
| Cytogenesis |
Acquired by BresaGen, Nov 2000 |
| Cytomed |
Operations acquired by UCB Pharma, Feb 1999 |
| Cytomyx |
Acquired by Origene, fka Cambridge Bioscience |
| Cytonet |
Key Assets acquired by Prometera Biosciences, Apr 2016 |
| Cytopeia |
Acquired by BD, May 2008 |
| Cytopia |
Acquired by YM Biosciences, Oct 2009, $14M |
| CytoSen Therapeutics |
Acquired by Kiadis Pharma, Jun 2019 |
| CytoTherapeutics |
Acquired and took on StemCells Inc name |
| Cytune Pharma |
Bought by SOTIO, Aug 2018 |
| Cytyc |
Acquired by Hologic, May 2007, $6.2B |
| CyVek |
Acquired by Bio-Techne, 2014 |
| Dako |
Bought by Agilent, May 2012, $2.2B |
| Darwin Molecular |
Acquired by Chiroscience, Nov 1996, $120M stock |
| Dascena |
Acquired by CirrusDx, Aug 2022 |
| Dasgip |
Acquired by Eppendorf, Jan 2012 |
| Davol |
Acquired by Bard, 1980 |
| DCPrime |
Acquired by Immunicum, Dec 2020 |
| deepCDR Biologics |
Acquired by Alloy Therapeutics, Dec 2021 |
| Definiens |
Acquired by MedImmune, Nov 2014 |
| Degge Group |
Acquired by PharmaLex, Apr 2014 |
| Delenex Therapeutics |
Bought by Cell Medica, Jul 2016 |
| Delinia |
Bought by Celgene, Jan 2017, $300M + $475 milestones |
| Delivra |
Bought by Harvest One Cannabis, Mar 2019 |
| Delphi Genetics |
Acquired by Catalent, Feb 2021 |
| Dendritic Nanotechnologies |
Acquired by starpharma, Oct 2006 |
| Denovium |
Acquired by AbSci, Jan 2021 |
| Derma Sciences |
Acquired by Integra, Feb 2017, $240M |
| Dermik Laboratories |
Owned by Sanofi, Acquired by Valeant Jul 2011 |
| Dermira |
Bought by Eli Lilly, Feb 2020, $1.1B |
| Devgen |
Bought by Syngenta, Sep 2012 |
| Dey LP |
Bought by Mylan 2007 |
| Dezima Pharma |
Acquired by Amgen Sep 2015, $300M+$1.2B milestones |
| Dfine |
Acquired by Merit Medical, Jul 2016, $98M |
| DFS Pharma |
Acquired by Medrio, Apr 2021?; fka DataFlex Solutions |
| Dharmacon |
Bought by Horizon Discovery, Jul7 2017, $85M |
| Diagnoplex |
Assets acquired by Novigenix, Feb 2015 |
| Diagnostic Hybrids |
Acquired by Quidel, Nov 2013, $130M |
| DiaKine Therapeutics |
Acquired by Islet Sciences Mar 2012 |
| Diamed |
Bought by Bio-rad |
| Diartis Pharmaceuticals |
Bought out by investors, Mar 2013. Not sure what will happen |
| Diatherix Laboratories |
Acquired by eurofins, $50M |
| Diffinity Genomics |
Acquired by Chiral Technologies, Aug 2015 |
| Dilyx Biotechnologies |
Acquired by Soluble Therapeutics, Oct 2014 |
| Dimension Therapeutics |
Bought by Ultragenyx, Nov 2017 |
| Dionex |
Bought by Thermo Fisher, Dec 2010, $2.1B |
| Diopsys |
Acquired by LumiThera, Mar 2022 |
| Diosynth |
Bought by Organon, Jan 2005 |
| Disarm Therapeutics |
Acquired by Eli Lilly, Oct 2020, $135M + $1.225B milestones |
| Discovery Genomics |
Acquired by Immusoft, Mar 2016 |
| Discuva |
Acquired by Summit Therapeutics, Dec 2017, £10M |
| Distributed Bio |
Acquired by Charles River, Jan 2021, $83M + $21M milestones |
| Diteba Research Laboratories |
Acquired by Nutrasource Diagnostics |
| Divergence |
Bought by Monsanto |
| DNA Therapeutics |
Acquired by Onxeo, Mar 2016, €1.7M |
| DNAprint Genomics |
Acquired by Nanobac Pharmaceuticals, Feb 2008 |
| DNAx |
Acquired by Schering-Plough, Apr 1982 |
| Dogma Therapeutics |
Product acquired by AstraZeneca, Sep 2020; Residential address |
| Dokumeds |
Acquired by Rho, Dec 2021 |
| DOV Pharmaceuticals |
Acquired by Euthymics |
| Dova Pharmaceuticals |
Acquired by Swedish Orphan Biovitrum, Nov 2019, up to $915M |
| Dow Pharmaceutical Sciences |
Bought by Valeant Dec 2008, Wound down late 2013 |
| Draxis Pharma |
Bought by Jubilant 2008 |
| Dream Pharma |
Acquired by Alvogen $186M, Jun 2014 |
| Dropprint Genomics |
Acquired by Immunai, Mar 2021 |
| Dropworks |
Acquired by Bio-rad, 2021 |
| Dualogics |
Platform acquired by AbCellera, Aug 2020 |
| Ducentis BioTherapeutics |
Acquired by Arcutis Biotherapeutics, Sep 2022, $30M + $370M milestones |
| Dune Medical Devices |
Acquired by Dilon Technologies, Apr 2020 |
| DuPont Pharmaceuticals |
Bought by BMS, Oct 2001, $7.8B |
| Duramed |
Acquired by Barr Labs 2001 |
| Durata Therapeutics |
Acquired by Actavis, Nov 2014, $675M |
| DUSA Pharmaceuticals |
Part of Sun Pharmaceuticals |
| DVS Sciences |
Acquired by Fluidigm, Jan 2014, $207M |
| Dyax |
Bought by Shire, Jan 2016, $5.9B |
| Dynacare |
Bought by LabCorp 2002 |
| eBioscience |
Acquired by Affymetrix, Nov 2011, $330M |
| Eclipse Therapeutics |
Bought by Bionomics, Sep 2012, $10M |
| Eden Biodesign |
Bought by Watson |
| Edge Therapeutics |
Acquired by PDS biotechnology, reverse merger, Mar 2019 |
| Edico Genome |
Acquired by Illumina, May 2018 |
| EEL transcriptomics |
Assets acquired by Rebus Biosystems, Dec 2021 |
| EganLee - Trial Focus |
Acquired by Precision for Medicine |
| EGEN |
Acquired by Celsion, Jun 2014 |
| Egenix |
Assets acquired by Bantam Pharmaceutical, Aug 2015 |
| EKR Therapeutics |
Bought by Cornerstone Therapeutics 2012 |
| Elan |
Bought by Perrigo, Dec 2013 |
| Elastagen |
Acquired by Allergan, Feb 2018, $95M |
| Element Genomics |
Acquired by UCB, Apr 2018, up to $30M |
| Elevation Pharmaceuticals |
Bought by Sunovion, $430M, Aug 2012 |
| Elion Labs |
Acquired by KBI Biopharma, Jan 2018 |
| Ellipse Technologies |
Bought by NuVasive, Jan 2016, $380M |
| Elto Pharma |
Bought by Coeptis Pharmaceuticals, Nov 2018 |
| Elucigene Diagnostics |
Bought by Yourgene Health, Apr 2019 |
| Elusys Therapeutics |
Acquired by Heat Biologics, Apr 2022 |
| Emas Pharma |
Acquired by Bionical, Nov 2016 |
| Embla Systems |
Acquired by Natus Medical, Sep 2011 |
| Emerald Biostructures |
Acquired and renamed Beryllium |
| Emisphere |
Acquired by Novo Nordisk, Dec 2020, $1.8B |
| Emphasys Medical |
Assets acquired by Pulmonx, May 2009 |
| Empirica Therapeutics |
Acquired by Century Therapeutics, Jun 2020 |
| Enantigen Therapeutics |
Acquired by OnCore Biopharma Oct 2014 |
| EnBiotix |
Acquired by Polyphor, Oct 2021 |
| Encore Vision |
Bought by Novartis, Dec 2016 |
| Encycle Therapeutics |
Acquired by Zealand Pharma, Oct 2019, up to $80M |
| Encysive Pharmaceuticals |
Bought by Pfizer 2008; fka Texas Biotechnology Corp |
| EndoChoice |
Acquired by Boston Scientific, Nov 2016, $210M |
| Endoclear |
Acquired by Avanos, Nov 2019 |
| Endocyte |
Bought by Novartis, Dec 2018, $2.1B |
| enEvolv |
Acquired by Zymergen, Mar 2020 |
| Engage Surgical |
Acquired by Smith + Nephew, Jan 2022, $135M |
| Engage Therapeutics |
Acquired by UCB, Jun 2020, $125M |
| EngMab |
Bought by Celgene, Sep 2016, $625M + $2.4B milestones |
| Enigma Therapeutics |
Acquired by NeuroDiscovery, Feb 2013 |
| enobia pharma |
Acquired by Alexion Feb 2012 |
| Enochian Biopharma |
Acquired by DanDrit Biotechnology, Feb 2018 |
| Ensure Medical |
Acquired by Cordis, Jul 2006, up to $90M |
| Entellus Medical |
Acquired by Stryker, Feb 2018, $662M |
| Enteric Medical |
Bought by Boston Scientific, Jun 2002, $300M |
| Envigo |
Acquired by Inotiv, Nov 2021; Swapped assets with Covance to exit preclinical CRO business |
| Envision Medical |
Bought by BMS, Aug 1996 |
| Envoy Therapeutics |
Acquired by Takeda, Nov 2012 |
| Enzymatics |
Bought by Qiagen, Jan 2015, Colorado facility spun off as ArcherDx |
| Epic Therapeutics |
Acquired by Baxter, Nov 2002, $50M+ |
| Epicentre |
Acquired by Illumina, Jan 2011 |
| Epicyte Pharmaceutical |
Acquired by Biolex May 2004 |
| Epinomics |
Acquired by 10X Genomics, Aug 2018 |
| EpiTherapeutics |
Bought by Gilead, May 2015, $65M |
| Epitome Biosystems |
Assets acquired by Millipore, 2009 |
| Epitomics |
Bought by Abcam, Mar 2012, $155M |
| EPIX Therapeutics |
Bought by Medtronic, Jan 2019, $316M |
| Epixis |
Acquired by VBI Vaccines |
| Epocal |
Acquired by Alere, Feb 2013 |
| Epoch Biosciences |
Acquired by Nanogen, Sep 2004 |
| EpsilenBio |
Acquired by Chroma Medicine, Nov 2021 |
| Eragen Biosciences |
Bought by Luminex 2011 |
| Ercole Biotech |
Acquired by AVI Biopharma 2008 |
| EsbaTech |
Bought by Alcan |
| Esoterix |
Bought by LabCorp, May 2005 |
| Esperion Therapeutics (1) |
Acquired by Pfizer early 2004 $1.3B |
| Essen BioScience |
Bought by Sartorius, Apr 2017, $320M; fka Essen Instruments |
| Estudysite |
Acquired by Velocity Clinical, Dec 2020 |
| ETHICAL ONCOLOGY SCIENCE |
Acquired by Clovis Oncology, Nov 2013 |
| Euprotein |
Acquired by Meridian Bioscience, Apr 2022 |
| Eureka Genomics |
Acquired by Affymetrix, May 2015, $14M |
| Eurofins DiscoverX |
Acquired by Eurofins, Jul 2017; fka Discoverx |
| EUROIMMUN |
Acquired by PerkinElmer, Dec 2017, $1.3B |
| EUSA Pharma |
Acquired by Recordati, Dec 2021, $850M; Spun out of Jazz, Mar 2015; Acquired by Jazz Pharmaceuticals, Apr 2012, $700M |
| Euthymics Biosciences |
Assets acquired by Ethismos Research, Nov 2017 |
| Euticals |
Bought by AMRI, May 2016, $358M |
| ev3 |
Acquired by Covidien, Jul 2010, $2.6B |
| Evalve |
Owned by Abbot Vascular |
| Evergreen Medical Technologies |
Acquired by Haraeus |
| Exalenz Bioscience |
Acquired by Meridian Bioscience, Apr 2020 |
| Excaliard |
Bought by Pfizer 2011 |
| Excelsior Medical |
Acquired by ICU Medical, Oct 2015 |
| Excelsyn |
Bought by AMRI |
| Eximias Pharmaceutical |
Acquired by YM BioSciences, May 2006 |
| Eximo Medical |
Acquired by AngioDynamics, Oct 2019, $46M + $20M milestones |
| Exiqon |
Acquired by Qiagen, Oct 2017 |
| Exocell |
Acquired by Ethos Biosciences, Nov 2018 |
| Exonics Therapeutics |
Acquired by Vertex, Jun 2019, $245M |
| Expedeon |
Acquired by Abcam, Jan 2020; Acquired by SYGNIS, Jun 2017, €11.5M |
| ExplORer Surgical |
Acquired by GHX, Oct 2021 |
| Expression Analysis |
Acquired by Quintiles, Aug 2012 |
| EXPUTEC |
Acquired by Korber Group, Jun 2020 |
| Exquiron |
Acquired by Aptuit, Apr 2016 |
| Eyevance Pharmaceuticals |
Acquired by Santen, Sep 2020 |
| Fabrus |
Acquired by Sevion Therapeutics, May 2014 |
| Facet Biotech |
Bought by Abbott 2010 |
| Fairhaven Pharmaceuticals |
Acquired by Liminal BioSciences, Jul 2020 |
| Falcon Pharmaceuticals |
Bought by Sandoz from Alcon Oct 2011 |
| Famy Life Sciences |
|
| Fathom Pharma |
Acquired by Consegna Pharma, Apr 2022 |
| Faulk Pharmaceuticals |
Bought by Panther Biotechnology, Jul 2015, stock plus royalty |
| Faxitron Bioptics |
Acquired by Hologic, Jul 2018, $85M |
| FazaClo |
Acquired by Azur Pharma 2007 |
| Fermentas |
Acquired by Thermo Fisher, May 2010, $260M |
| Ferrokin Biosciences |
Bought by Sandoz Jul 2012, $1.525B |
| Fibrocell Science |
Acquired by Castle Creek Pharmaceuticals, Dec 2019; fka Isolagen |
| Fidelta |
sold by Galapagos to Selvita, Nov 2020, $37M |
| Finox Biotech |
Acquired by Gedeon Richter, Jun 2016 |
| Firefly BioWorks |
Acquired by abcam, Jan 2015, $28M |
| FirstString Research |
Renamed Xequal May 2022; Acquired by Relief Therapeutics, Jul 2016 |
| Five Prime Therapeutics |
Acquired by Amgen, Apr 2021, $1.9B |
| Flame Biosciences |
Acquired by Leap Therapeutics, Jan 2023 |
| Flaskworks |
Acquired by Northwest Biotherapeutics, Sep 2020 |
| Flexion Therapeutics |
Acquired by Pacira BioSciences, Nov 2021 |
| Flexus Biosciences |
Bought by BMS, Feb 2015, $800M + $450M milestones |
| Flow Forward Medical |
Acquired by Artio Medical, Jul 2020 |
| FluoFarma |
Acquired by Porsolt, Dec 2015 |
| Focal Therapeutics |
Acquired by Hologic, $125M, Oct 2018 |
| Focus-X Therapeutics |
Acquired by Full Life Technologies, Nov 2022, up to $245M |
| Foguera |
Bought by Sandoz Jul 2012, $1.525B |
| Foldrx Pharmaceuticals |
Bought by Pfizer, Sep 2010 |
| Forendo Pharma |
Acquired by Organon, Dec 2021, $954M |
| Foresight Biotherapeutics |
Bought by Shire, Aug 2015, $300M |
| Forest Laboratories |
Bought by Actavis, Jul 2014, $25B |
| FORMA Therapeutics |
Acquired by Novo Nordisk, Oct 2022, $1.1B |
| Fornix Biosciences |
Acquired by skiing company in reverse merger, Dec 2013 |
| ForSight VISION4 |
Acquired by Roche, Jan 2017 |
| ForSight VISION5 |
Acquired by Allergan, Aug 2016, $95M |
| Forte Bio |
Folded into Sartorious after purchasing from Danaher, Oct 2019 |
| Forty Seven |
Acquired by Gilead, Apr 2020, $4.9B |
| Forward Clinical Trials |
Acquired by Cenexel, Aug 2021 |
| Fournier Pharma |
Acquired by Solvay, 2006 |
| Fovea Pharmaceuticals |
Acquired by Sanofi Oct 2009 |
| Frame Cancer Therapeutics |
Acquired by CureVac, Jun 2022 |
| Freedom Meditech |
Acquired by Trividia Health, Jan 2017 |
| Frontida BioPharm |
Acquired by Adare Pharma Solutions, Dec 2021 |
| Frontier Global Sciences |
Acquired by eurofins, Sep 2012 |
| Frugi Biotechnology |
Acquired by BigHat Biosciences, Mar 2022 |
| FSC Pediatrics |
Acquired by Flamel, merged into Avadel Pharmaceuticals Jan 2017 |
| Funxional Therapeutics |
Bought by Boehringer Ingelheim, Jul 2012 |
| Furiex Pharmaceuticals |
Acquired by Forest Labs, Apr 2014 |
| G7 Therapeutics |
Acquired by Heptares, Nov 2016, $12M |
| Gadea Pharmaceutical |
Acquired by AMRI, 2015, $174M |
| Gala Biotech |
Acquired by Catalent Pharma Solutions, ~Jul 2007 |
| Galena Biopharma |
Acquired via Reverse Merge by Sellas Life Sciences, Aug 2017 |
| Galil Medical |
Acquired by BTG plc, May 2016 |
| Gallus |
Bought by Patheon, Aug 2014 |
| Gallus Immunotech |
Acquired by Exalpha Biologicals, Jun 2018 |
| Gambro |
Acquired by Baxter, Sep 2013 |
| GammaDelta Therapeutics |
Acquired by Takeda, Oct 2021 |
| GAMUT Therapeutics |
Acquired by SparingVision, Apr 2021 |
| GandTex |
Assets Acquired by SmooFi, Oct 2016 |
| Ganymed Pharmaceuticals |
Bought by Astellas, Dec 2016, $1.4B |
| GATC Biotech |
Acquired by eurofins, Jun 2017 |
| Gauss Surgical |
Acquired by Stryker, Sep 2021 |
| GAVIS PHARMACEUTICALS |
Acquired by Lupin |
| GD Searle |
Acquired by Monsanto 1985, Merged into Pharmacia, name retired in 2003 after Pfizer acquisition |
| GE Healthcare |
Acquired by Danaher, Apr 2020, $21.4B, rebranded as Cytiva |
| Geltex Pharmaceuticals |
Bought by Genzyme |
| Gema Biotech |
Acquired by AMEGA biotech, early 1990s |
| Gemin X |
Acquired by Cephalon Mar 2011 |
| Gemini Laboratories |
Acquired by Amneal, May 2018 |
| GEMoaB Monoclonals |
Being acquired/relocated by consortium, Jun 2021, now part of Avancell |
| Gemphire Therapeutics |
Acquired via Reverse Merger by NeuroBio, Dec 2019 |
| Gen-probe |
Acquired by Hologic 2012 |
| Gen9 Bio |
Bought by Ginkgo Bioworks, Jan 2017 |
| Genable Technologies |
Bought by Spark Therapeutics, Mar 2016, $15M |
| Genaco Biomedical |
Acquired by Qiagen 2006 |
| Genae Associates |
Acquired by IQVIA |
| Genaissance Pharmaceuticals |
Acquired by Clinical Data, Jun 2005 |
| GenCell Biosystems |
Acquired by BD, Oct 2014 |
| Gene Labs |
Bought by GSk 2008 |
| GeneDx (old) |
Acquired by Sema4, Jan 2022, $623M |
| Genelabs Technologies |
Acquired by GSK, Oct 2008, $57M |
| Genelex |
Acquired by Invitae, Mar 2020 |
| GeneLogic |
Bought by Ocimum, Oct 2007, $10M; bankrupt Dec 2011 |
| Genencor |
Bought by DuPont |
| GenePOC Diagnostics |
Acquired by Meridian Bioscience, Apr 2019, $50M + $70M milestones |
| GeneSeek |
Bought by Neogen |
| Genesoft Pharmaceuticals |
Acquired by Genome Therapeutics, Nov 2003 |
| Genetic Systems |
Bought by Bristol-Myers, 1986 |
| Genetic Therapy |
Bought by Sandoz, Jul 1995, #295M |
| Genetics Institute |
Bought by Wyeth, Sep 1996 |
| GeneTx Biotherapeutics |
Acquired by Ultragenyx, Jul 2022, $75M |
| GeneWEAVE Biosciences |
Bought by Roche, Aug 2015, $190M |
| Genexx |
Acquired by Opko Health , Oct 2009 |
| Genhelix |
Acquired by mAbxience, Jun 2014 |
| Genia Technologies |
Acquired by Roche, Jun 2014 |
| Genkyotex |
Acquired by Calliditas, Nov 2020 |
| GenoLogics |
Acquired by Illumina, Sep 2015 |
| GenoMatix |
Acquired by Intrexon |
| Genome Explorations |
Acquired by Tesis Biosciences, Feb 2022 |
| Genomic Health |
Acquired by Exact Sciences, Nov 2019, $2.8B |
| Genomic Solutions |
Acquired by Digilab |
| Genomics Collaborative |
Acquired by BioServe, 2007 |
| Genopis |
Acquired by Wacker Feb 2021 |
| Genoptix |
Bought by Novartis Jan 2011, sold off Jan 2017, bought by Neogenomics, Dec 2018, $125M + 1 million shares |
| Genos |
Acquired by NantOmics, Apr 2017 |
| Genosity |
Bought by Invitae, Apr 2021, $200M |
| Genpathway |
Acquired by Active Motif, Nov 2010 |
| Gentium |
Bought by Jazz Pharmaceuticals, Jan 2014, $1B |
| Gentris |
Bought by Cancer Genetics Jun 2014 ($6.5M) |
| GenturaDx |
Bought by Luminex 2012 |
| GenVec |
Bought by Intrexon, Jun 2017, $16M in stock |
| Genzyme |
Acquired by Sanofi, 2011, $20.1B |
| Genzyme Genetics |
Bought by LabCorp, Dec 2010 |
| Geospiza |
Acquired by Perkin Elmer, May 2011, $?? |
| Gideon Pharmaceuticals |
Acquired by Elorac Pharmaceuticals, Apr 2016 |
| Glamorous AI |
Acquired by X-Chem, Oct 2021 |
| Global Blood Therapeutics |
Acquired by Pfizer, Oct 2022, $5.4B |
| GlobalCare Clinical Trials |
Acquired by Covance, Jul 2020 |
| Gloucester Pharma |
Bought by Celgene 2009 |
| Gloucester Pharmaceuticals |
Acquired by Celgene, Dec 2009, $340M + $300M milestones |
| GlyCart Biotechnology |
Acquired by Roche, Jul 2005 |
| GlycoFi |
Bought by Merck, $400M, 2006 |
| GlycoVaxyn |
Acquired by GSK, Feb 2015, $190M |
| GLyPharma Therapeutic |
Acquired by Theracon, Oct 2018 |
| GN Otometrics |
Acquired by Natus, Jan 2017 |
| GnuBIO |
Bought by Bio-rad |
| goBalto |
Acquired by Oracle, Oct 2018 |
| Good Start Genetics |
Acquired by Invitae, Aug 2017 |
| Good Therapeutics |
Acquired by Roche, $250M, renamed Bonum Therapeutics |
| GoodStart Genetics |
Acquired by Invitae, Aug 2017 |
| GPC Biotech |
Acquired by Agennix, Nov 2009 |
| Grace Therapeutics |
Acquired by Acasti, Aug 2021 |
| Graceway Pharmaceuticals |
Bought by Medicis out of Bankruptcy |
| Greenwich Biosciences |
Acquired by Jazz Pharmaceuticals, May 2021 |
| Griffin Laboratories |
Acquired by Atos Medical |
| GSL Biotech |
Acquired by Dotmatics |
| GTx |
Acquired by Oncternal via reverse merger ticker, Jun 2019 |
| Guide Therapeutics |
Website down Oct 2021 - Dec 2021; Acquired by BEAM Therapeutics, Feb 2021, $120M + $320M Milestones |
| Guilford Pharmaceuticals |
Bought by MGI Pharma, Jul 2005 |
| Gyrus |
Acquired by Olympus, 2008, $2B |
| H-Immune Therapeutics |
Acquired by HiFiBiO, Oct 2018 |
| Haemostatix |
Acquired by Ergomed, May 2016 |
| Hain Lifescience |
Acquired by Bruker, Oct 2018 (80% stake) |
| Haina Pharmaceutical |
Acquired by China Sky One, $428k, Apr 2008 |
| HalioDx |
Acquired by Veracyte, Aug 2021 |
| Halo Genomics |
Bought by Agilent |
| Halo Pharma |
Acquired by Cambrex, Sep 2018, $425M |
| Handl Therapeutics |
Acquired by UCB, Nov 2020 |
| Hansen Medical |
Bought by Auris Surgical, Apr 2016, $40M |
| Harbor Therapeutics |
Acquired by Crede Capital Group, Jan 2015. Website gone. |
| Harbour Antibodies |
Acquired by Harbour Biomed, Dec 2016 |
| Harrisvaccines |
Bought by Merck Animal Health, Nov 2015 |
| Hauser Pharmaceutical Services |
Acquired by Cedarburg |
| Hawthorn Pharmaceuticals |
Acquired by Pernix Jan 2012 |
| Haystack Sciences |
Acquired by insitro, Oct 2020 |
| HD Biosciences |
Acquired by WuXi Apptec, Jan 2016 |
| Health Advances |
Bought by Parexel, Jan 2016 |
| Health Decisions |
Acquired by Premier Research, Jul 2021 |
| Health-Chem Diagnostics |
Acquired by PL Developments, Jul 2017 |
| HealthPoint Bio |
Bought by Smith & Nephew |
| Healthpoint Biotherapeutics |
Acquired by Smith & Nephew, Sep 2013, $782M |
| HeartWare |
Bought by Medtronic, Aug 2016, $1.1B |
| Helio Vision |
Bought by Aldeyra Therapeutics, Jan 2019, $10M |
| Helix Diagnostics |
Acquired by Bio-rad, Jul 2001 |
| Hemacare |
Acquired by Charles River Labs, Jan 2020, $380M |
| Hematech |
Acquired by Sanford Health, Jan, 2013, became Sanford Applied Biosciences |
| Hemmo Pharmaceuticals |
Acquired by Piramal, Apr 2021, $106M + Milestones |
| Henogen |
Acquired by Novasep, Jul 2009 |
| Heptares Therapeutics |
Acquired by Sosei Group, Feb 2015 |
| Hercon Pharmaceuticals |
Acquired by Zydus Cadila, 2019 |
| Hi-Tech Pharmacal |
Acquired by Akorn, Apr 2014 |
| Hibiskus Biopharma |
Acquired by Lodo Therapeutics, Sep 2020 |
| HighPoint Solutions |
Acquired by IQVIA, Oct 2017 |
| HistoRx |
Acquired by Genoptix Sep 2012 |
| HistoTox Labs |
Acquired by Inotiv, Apr 2021, $22M |
| Horizon Discovery |
Acquired by Perkin Elmer, Oct 2020, $383M |
| Hospira |
Acquired by Pfizer, Sep 2015 |
| Hotspur Technologies |
Acquired by Teleflex, Jul 2012 |
| HRA Pharma |
Acquired by Perrigo, May 2022, $2.1B |
| Humabs BioMed |
Bought by Vir Biotechnology, Aug 2017 |
| Human Genome Sciences |
Bought by GSK |
| HumanZyme |
Acquired by Proteintech, Apr 2018 |
| Hybritech |
Bought by Lilly, 1986, $400M+ |
| Hygia Health Services |
Acquired by Stryker, May 2018 |
| Hyperion Therapeutics |
Bought by Horizon Pharma Mar 2015 $1.1B |
| Hypnion |
Acquired by Eli Lilly, Mar 2007 |
| Hyseg Pharmaceuticals |
Acquired by ARCA Biopharma, Jan 2009 |
| Ibis Biosciences |
Acquired by Abbott Jan 2009 |
| Icagen (1) |
Acquired by Pfizer Oct 2011, Renamed Neusentis Mar 2012, Icagen name and assets acquired by XRPro Sciences Jul 2015 |
| Icagen (2) |
Acquired by Ligand Apr 2020; Purchased Icagen assets from Pfizer |
| ICBiotec |
Acquired by eGenesis, May 2020 |
| Ichorion Therapeutics |
Acquired by Cerecor, Sep 2018, $26.6M |
| Icon Bioscience |
Acquired by pSivida, rebranded as EyePoint Pharmaceuticals |
| Iconix Biosciences |
Acquired by Entelos, Aug 2007 |
| Icos |
Acquired by Eli Lilly, 2006, $2.2B |
| ID Biomedical |
Acquired by GSK, Sep 2005, $1.7B |
| ID Pharma |
Acquired by I'rom Group |
| IDbyDNA |
Acquired by Illumina, Jun 2022 |
| Idenix Pharmaceuticals |
Bought by Merck, Jun 2014 |
| IDEV Technologies |
Bought by Abbott, Jul 2013, $310M |
| IDM Pharma |
Acquired by Takeda |
| Idun Pharmaceuticals |
Acquired by Pfizer Feb 2005, Acquired by Conatus Pharmaceuticals Aug 2010 |
| IFM Therapeutics (1) |
Acquired by BMS after less than a year, $300M + $1B milestones. Spinning out some assets into new company with same name |
| Igenica Biotherapeutics |
Assets acquired by Pierre Fabry, May 2017 |
| iGenomX |
Acquired by Twist Biosciences, Jun 2021 |
| Ignyta |
Acquired by Roche, Feb 2018; $1.2B |
| Ikaria |
Acquired by Mallinckrodt, Apr 2015 |
| iLab Solutions |
Assets acquired by Agilent, Aug 2016 |
| ILEX Oncology |
Acquired by Genzyme, Dec 2004, $1B in stock |
| Ilypsa |
Bought by Amgen $420M Jun 2007 |
| Imaging Advantage |
Acquired by Envision Healthcare, Mar 2017 |
| Imago Biosciences |
Acquired by Merck, Jan 2023, $1.35B |
| Imara |
Acquired by Enliven Therapeutics, Oct 2022 |
| imarc |
Acquired by Avania, Jun 2021 |
| ImaRx |
Assets acquired by newly formed Cerevast Therapeutics in 2009 |
| ImClone |
Bought by Lilly, Oct 2008, $6.5B |
| Imgenex |
Acquired by Novus Biologicals Oct 2013 |
| Immco Diagnostics |
Acquired by Trinity Biotech, Aug 2013, $33M |
| ImmuMetrix |
Bought by CareDx Jun 2014 |
| Immune Design |
Bought by Merck, Feb 2019, $300M |
| Immunetics |
Acquired by Oxford Immunotec, Oct 2016 |
| Immunex |
Bought by Amgen, Jul 2002, $16B |
| ImmunoCellular Therapeutics |
Rebranded as EOM Pharmaceuticals, Nov 2022; Assets bought Aug 2019, $500k |
| Immunomedics |
Acquired by Gilead, Oct 2020 |
| Impac Medical Systems |
Acquired by Elekta, Jan 2005 |
| Impact Biomedicines |
Bought by Celgene, Jan 2018, up to $7B |
| Impilo Therapeutics |
Acquired by CEND Therapeutics, Sep 2020 |
| Impopharma |
Acquired by Rubicon Research, Jan 2020 |
| ImThera Medical |
Acquired by LivaNova, Dec 2017 |
| Imugen |
Acquired by Oxford Immunotec, Jul 2016, $22M |
| In Vitro ADMET Laboratories |
Acquired by Discovery Life Sciences, Dec 2021 |
| Incisive Surgical |
Acquired by CooperSurgical, Jan 2019 |
| Incline Therapeutics |
Acquired by The Medicines Company, Dec 2012 |
| Indevus |
Acquired by Endo Pharmaceuticals 2009 |
| Indicia Biotechnology |
Acquired by Platine Pharma Services, Jun 2013 |
| IndiPharm |
Acquired by private equity to be relaunched as InClinica |
| IndUS Pharmaceuticals |
Bought by Pivot Pharmaceuticals, Nov 2015 |
| Inexia |
Acquired by Centessa |
| InfaCare |
Acquired by Mallinckrodt, Sep 2017, $80M + $345M milestones |
| Inflazome |
Acquired by Roche, Sep 2020, $450M |
| InGen Biosciences |
Acquired by Exonhit 2012 |
| Ingenuity Systems |
Bought by Qiagen, renamed Ingenuity, folded into Qiagen |
| Inhibitex |
Acquired by BMS 2012, $2.5B |
| Injex Pharma |
Bought by Chinese Investor, Jan 2016 |
| Innate Immunotherapeutics |
Acquired Amplia Therapeutics, took its name |
| InnAVasc Medical |
Acquired by W.L. Gore, Aug 2022 |
| InnFocus |
Acquired by Santen, Jul 2016 |
| Innocutis |
Acquired by Cipher Pharmaceuticals, Apr 2015 |
| Innogenetics |
Acquired by Fujirebio Europe, Sep 2010 |
| InnoPharma |
Acquired by Pfizer, Sep 2014, $225M + $135M milestones |
| Innovative Therapies |
Acquired by Cardinal Health, Aug 2014 |
| Innovus Pharmaceuticals |
Acquired by Aytu Bioscience, Feb 2020 |
| Inositec |
Acquired by Vifor Pharma, Nov 2021, CHF20M |
| Inova Diagnostics |
Acquired by Werfen, 2008 |
| Inova Labs |
Bought by ResMed, Jan 2016 |
| Inpharmatica |
Acquired by Galapagos, Jul 2019 |
| Insight Genetics |
Acquired by Oncocyte, Feb 2020 |
| Insight Pharmaceuticals |
Acquired by Prestige Brands, Apr 2014, $650M |
| InSilico Solutions |
Acquired by Kiromic, Jul 2021 |
| InSite Vision |
Acquired by Sun pharma Sep 2015 |
| Inspire Pharmaceuticals |
Acquired by Merck 2011 |
| Instratek |
Assets acquired by Stryker, Sep 2016 |
| InstruNor |
Acquired by Fluidigm, Feb 2020 |
| InSymbiosis |
Acquired by Camargo, Jun 2019 |
| Intabio |
Acquired by SCIEX, Jan 2021 |
| Intact Vascular |
Acquired by Philips, Aug 2020, $275M |
| Intec Pharma |
Acquired by Decoy Biosystems via Reverse Merger, Aug 2021 |
| INTEGA Skin Sciences |
Acquired by Crescita Therapeutics, Sep 2016 |
| IntegenX |
Acquired by Thermo Fisher, Mar 2018 |
| Integrated Diagnostics |
Acquired by Biodesix, Jul 2018 |
| Integrated Diagnostics (2) |
Acquired by Biodesix, Jul 2018 |
| Integrated Laboratory Systems |
Acquired by Inotiv, Jan 2022, $56M |
| Integrated Proteomics Applications |
Acquired by Bruker, Sep 2020 |
| Integrity Bio LyoTip |
Acquired by Curia, Jul 2021 |
| Integromics |
Bought by Perkin-Elmer 2017 |
| InteKrin |
Owned by Coherus Biosciences |
| Intellicyt |
Acquired by Sartorius, Jun 2016, $90M |
| Intelligent Biosystems |
Acquired by Qiagen, Jun 2012 |
| Intellikine |
Bought by Millennium 2011 |
| IntelliSyn R&D |
Acquired by X-Chem, Jan 2021 |
| Intendis |
Acquired by Bayer 2006, Renamed Bayer Health Care 2012 |
| Interferon Source |
Bought by PBL Assay Science |
| InterMune |
Bought by Roche, Aug 2014, 8.5B |
| Interpares Biomedicine |
Acquired by Clarified Precision Medicine, Aug 2021 |
| Intersect ENT |
Acquired by Medtronic, May 2022, $1.1B |
| Intrafuse |
Tech acquired by Conventus Orthopedics, Dec 2019 |
| Intrinsic Bioprobes |
Acquired by Thermo Fisher Sep 2011 |
| Intronn |
Acquired by VIRxSYS, Sep 2007 |
| Inviragen |
Bought by Takeda, May 2013 Announced |
| Invitrogen |
Acquired by Thermo Fisher, Apr 2013, $13.6B |
| Invuity |
Acquired by Stryker, Oct 2018, $190M |
| Iogyn |
Acquired by Boston Scientific, May 2014 |
| Iomai |
Bought by Intercell 2008 |
| IOmet Pharma |
Acquired by Merck, Jan 2016, $400M |
| iperian |
Acquired by Bristol-Myers Squibb, Apr 2014, $175M |
| IPM Biotech |
Acquired by BioAgilytix, Feb 2016 |
| Iquum |
Acquired by Roche, Apr 2014 |
| IRIS International |
Acquired by Danaher, Sep 2012 |
| IRISYS |
Acquired by Recro, Aug 2021 |
| IROC Inocross |
Assets acquired by Avedro, Sep 2014 |
| Irvine Pharmaceutical Services |
Acquired by Nitto Denko Avecia, Oct 2016 |
| Irvine Scientific |
Acquired by Fujifilm, Jun 2018 |
| iScience Interventional |
Acquired by Ellex, Jan 2014 |
| IsoPlexis |
Acquired by Berkeley Lights, Mar 2023, $57.8M |
| Isotechnika |
Acquired and merged with Aurinia, Sep 2013 |
| Ista Pharmaceuticals |
Bought by Bausch & Lomb - 2012 |
| Italchimici |
Acquired by Recordati, May 2016 |
| ITC |
Acquired Accumetrics, Rebranded as Accriva Diagnostics |
| Ivantis |
Website down Feb 2023; Acquired by Alcon, Jan 2022, $475M |
| IVAX Corporation |
Acquired by Teva 2006 |
| Ivera Medical |
Bought by 3M, Feb 2015 |
| Jade Therapeutics |
Acquired by EyeGate Pharma, Mar 2016, stock |
| Janpix |
Acquired by Centessa Pharmaceuticals |
| Jantibody |
Acquired by H-Cyte, Sep 2022 |
| Jecure Therapeutics |
Acquired by Genentech, Nov 2018 |
| Jennerex |
Acquired by SillaJen, Nov 2013, up to $150M |
| Jerini |
Acquired by Shire, 2008 |
| JHP Pharma |
Bought by Par Pharmaceuticals |
| Jouvenal |
Bought by Warner-Lambert, 1997 |
| JSW Life Sciences |
Acquired by QPS, Jan 2012 |
| Jungla |
Acquired by Invitae, Jul 2019, $65M |
| Juniper Pharmaceuticals |
Acquired by Catalent, Aug 2018 |
| Juno Therapeutics |
Acquired by Celgene, Jan 2018, $9B |
| Just Biotherapeutics |
Acquired by Evotec, Jul 2019, up to $90M |
| K2M |
Acquired by Stryker, Nov 2018 |
| Kadmon |
Acquired by Sanofi, Sep 2021 |
| KAI Pharmaceuticals |
Bought by Amgen 2012 |
| KAI Research |
Acquired by Navitas Life Sciences |
| Kairos Therapeutics |
Acquired by Zymeworks |
| Kalila Medical |
Acquired by Abbott, Feb 2016 |
| Kalon Biotherapeutics |
Acquired by Fujifilm Diosynth Dec 2014 |
| KaNDy Therapeutics |
Acquired by Bayer, Sep 2020, $425M |
| Kantar Health |
Acquired by Cerner, Apr 2021, rebranded as Cerner Enviza |
| Kanyos Bio |
Acquired by Anokion, Sep 2019 |
| Kapa Biosystems |
Bought by Roche, Aug 2015 |
| Kapplex |
Acquired by Miroculus, Apr 2016 |
| Karos Pharmaceuticals |
Sold to Roivant Sciences, 2017 |
| Katena Products |
Acquired by Corza Medical, Dec 2021 |
| Kedalion Therapeutics |
Acquired by Novartis, Jun 2022 |
| Kemwell Biopharma |
Bought by Recipharm, Apr 2016, $205M |
| Kendle |
Acquired by INC Research 2011 |
| Kenta Biotech |
Assets acquired by Aridis Pharmaceuticals, May 2013 |
| Khepri Pharmaceuticals |
Acquired by Arris Pharmaceuticals Nov 1995 |
| Kiadis Pharma |
Acquired by Sanofi, Oct 2020, $357M |
| Kinaxo |
Bought by Evotec |
| Kinetic Discovery |
Acquired by Exscientia, Nov 2018 |
| Kinetix Pharmaceuticals |
Bought by Amgen 2000 |
| King Pharmaceuticals |
Bought by Pfizer, Oct 2010, $3.6B |
| Kiq |
Acquired by Unum Therapeutics, Jul 2020 |
| Kleo Pharmaceuticals |
Acquired by Biohaven, Jan 2021 |
| KMT Hepatech |
Acquired by PhoenixBio, Dec 2017 |
| Knoll Pharmaceutical |
Taken over by BASF 1975, sold to Abbott 2002 |
| Knome |
Acquired by Tute Genomice, Nov 2015 |
| Koligo Therapeutics |
Acquired by Orgenesis, Oct 2020 |
| Kolltan Pharmaceuticals |
Bought by Celldex, Nov 2016, $62.5M + $172.5M milestones |
| KorvaLabs |
Acquired by Curative, May 2020 |
| Kos Pharmaceuticals |
Acquired by Abbott 2006 |
| Kosan Biosciences |
Acquired by BMS 2008 |
| KPL |
Acquired by SeraCare, Aug 2013, Stock |
| Kreatech Diagnostics |
Acquired by Leica Biosystems, Jul 2013 |
| KuDOS Pharmaceuticals |
Acquired by AstraZeneca, Dec 2005, £120M |
| Kuur Therapeutics |
Acquired by Athenex, May 2021, $70M stock + $115M milestones; fka Cell Medica |
| KWS BioTest |
Acquired by Charles River, Jan 2018, £15M |
| Kyalin Biosciences |
Acquired by Retrophin, Dec 2013 |
| Kythera Biopharmaceuticals |
Bought by Allergan, Oct 2015, $2.1B |
| Lab901 |
Bought by Agilent |
| Labcyte |
Acquired by Beckman Coulter, Jan 2019 |
| Labopharm |
Bought by Paladin 2011 |
| Labor Dr. Merk |
Acquired by Boehringer Ingelheim, Dec 2020 |
| Laboratories Delalande |
Acquired by Synthélabo, 1991 |
| Labrys Biologics |
Bought by Teva, Jun 2014 |
| Lacrimedics |
Acquired by Innovia Medical, Nov 202 |
| Lake Region Medical |
Bought by Greatbatch, Oct 2015, $1.73B |
| LakePharma |
Acquired by Curia, Jul 2021 |
| Lancaster Laboratories |
Bought by eurofins, Apr 2011, $200M |
| Lanx inc |
Acquired by Biomet, Nov 2013, $150M |
| Lasergen |
Acquired by Agilent, Apr 2018, $105M |
| LAT Pharma |
Acquired by NanoAntibiotics, Apr 2016 |
| Laureate Pharma |
Acquired by Gallus |
| Lazarus Effect |
Acquired by Medtronic, Sep 2015, $100M |
| LDR Global |
Acquire by Zimmer Biomet, Jun 2016, $1B |
| LDR Holdings |
Bought by Zimmer Biomet, $1B, Jun 2016 |
| LEAD Therapeutics |
Acquired by BioMarin Pharmaceuticals, 2010 |
| Lederle Labs |
Bought by Wyeth 1994 |
| LemnaGene |
Acquired by Biolex 2005 |
| Lenetix |
Acquired by Bio-Reference Labs 2010 |
| Lentigen |
Acquired by Miltenyi Biotech, Apr 2014 |
| Leonard-Meron Biosciences |
Acquired by Citius Pharmaceuticals, Mar 2016 |
| LeukoSite |
Acquired by Millennium 1999 |
| Lexent Bio |
Acquired by Foundation Medicine, Jun 2020 |
| Libertas Pharma |
Acquired by Mayne Pharma, Jul 2013 |
| Librede |
Acquired by Lygos, Jan 2020 |
| Lidco |
Acquired by Masimo, Feb 2021 |
| Life Technologies |
Bought by Thermo-Fisher, Apr 2013, $13.6B |
| Lifecell |
Acquired by KCI, 2008, $1.7B; Sold to Allergan Dec 2016, $2.9B |
| Lifecode |
Acquired by MedGenome, Feb 2016 |
| Lifecode Health |
Assets Acquired by MedGenome, Feb 2016 |
| LigoCyte Pharmaceuticals |
Acquired by Takeda Oct 2012 |
| Lineage Therapeutics |
Acquired by Impax, Mar 2015 |
| Lineagen |
Acquired by Bionano Genomics, Aug 2020, $9.6M |
| Link Technologies |
Acquired by LGC, Jul 2017 |
| Linkage Biosciences |
Acquired by Thermo Fisher, Jul 2017 |
| Lipomics Technologies |
Acquired by Metabolon, Aug 2012 |
| Liponex |
Acquired by ImaSight in reverse merger, Jun 2008 |
| LipoScience |
Bought by LabCorp, Nov 2014, $85.3M |
| Liposonix |
Bought by Medicis |
| Living Pharma |
Acquired by Lentigen, Jul 2017 |
| Lobesity |
Assets acquired by 9 Meters Biopharma, Jul 2021, $5M + $45M milestones |
| Locemia Solutions |
Sole product acquired by Eli Lilly, Oct 2015 |
| Lodo Therapeutics |
Acquired by Zymergen, May 2021 |
| Lohmann Animal Health International |
Acquired by Elanco, Feb 2014 |
| Loop Genomics |
Acquired by Element Biosciences, Feb 2022 |
| Lotus Tissue Repair |
Acquired by Shire, Jan 2013, $49.3M + $275M milestones |
| Lowell Therapeutics |
Acquired by AcelRx Pharmaceuticals, Jan 2022 |
| LS9 |
Bought by Renewable Energy Group, Jan 2014 |
| Lucigen |
Acquired by LGC, Feb 2018 |
| LuinaBio |
Renamed AcuraBio, Aug 2022 |
| Lumara Health |
Bought by Amag, Sep 2014, $675M |
| Lumena Pharmaceuticals |
Bought by Shire, May 2014, $260M + $90M for milestone possibilities |
| Lumigen |
Bought by Beckman-Coulter, Oct 2006 |
| Lumora |
Bought by Erba Diagnostics Sep 2015, Rebranded Erba MDX |
| Lusochimica |
Owned by Menarini |
| Lutonix |
Acquired by C.R. Bard, Dec 2011 |
| Luxcel Biosciences |
Acquired by Agilent, Jan 2018 |
| Lynx Therapeutics |
Acquired by reverse merger with Solexa, 2005 |
| Lyophilization Services of New England |
Acquired by PCI Pharma Services, Dec 2021 |
| Lypro Biosciences |
Acquired by Cerenis Therapeutics, Nov 2017 |
| Lysosomal Therapeutics |
Acquired by BIAL, Sep 2020, rebranded BIAL Biotech |
| Mabpharm (1) |
Acquired by Cipla, Jul 2014 |
| Macroceutics |
Acquired by HotSpot Therapeutics, Aug 2019 |
| Macrochem |
Acquired by Access Pharmaceuticals, Feb 2009 |
| MacroCyclics |
Acquired by Areva, Oct 2011 |
| Macusight |
Effectively acquired by Santen, 2008 |
| Magnum Therapeutics |
Acquired by Introgen Therapeutics, Oct 2004 |
| Maine Biotechnology Services |
Acquired by BBI, Mar 2018 |
| Maine Standards Company |
Acquired by LGC, renamed LGC Main Standards, Nov 2015 |
| Makiz |
Acquired by Stada, Aug 2007, €125M |
| Mako Surgical |
Acquired by Stryker, Sep 2013, $1.65B |
| Manchester Pharmaceuticals |
Acquired by Retrophin, Mar 2014, $29.5M + $33M milestones |
| MAP Pharmaceuticals |
Acquired by Allergan 2013 |
| Marcadia Biotech |
Acquired by Roche Dec 2010 |
| MarDx |
Acquired by Fitzgerald Industries, 2007 |
| Maribo Medico |
Acquired by ResMed, Nov 2015 |
| Marker Gene Technologies |
Acquired by Abcam, Mar 2020 |
| Martek Biosciences |
Bought by DSM |
| Martindale Pharma |
Acquired by Ethypharm, Mar 2017 |
| Mast Therapeutics |
Bought by Savara for its public shell, Jan 2017 |
| MaSTherCell |
Acquired by Catalent, Feb 2020; Bought by Orgenesis, Mar 2015, $24M in shares |
| MateraCor |
Acquired by BioVentrix, Jan 2022 |
| Matritech |
Assets bought by Matritech 2007 |
| Maverick Therapeutics |
Acquired by Takeda, Oct 2021, $525M |
| Mavupharma |
Acquired by AbbVie, Jul 2019 |
| Maxer Endoscopy |
Acquired by Erbe Elektromedizin, Apr 2021 |
| Mazor Robotics |
Acquired by Medtronic, Dec 2018, $1.7B |
| MD Biosciences |
Acquired by MLM Medical Labs |
| med fusion |
Acquired by Quest Diagnostics, Jul 2017 |
| Meda Pharmaceuticals |
Acquired by Mylan, Aug 2016 |
| MedAlliance |
Acquired by Cordis, Oct 2022, $235M |
| Medarex |
Bought by BMS 2009 |
| MedCision |
Assets bought by MedCision, May 2018 |
| Medeor |
Acquired by Relmada Therapeutics, Dec 2013 |
| Mederi Medical |
Acquired by Restech, Apr 2018 |
| Medi-Tate |
Acquired by Olympus, May 2021 |
| Medicago |
Acquired by Mitsubishi Tanabe, Sep 2013, $357M |
| Medical Device Usability |
Acquired by UL, 2018 |
| Medicis Pharmacal |
Bought by Valeant Pharmaceuticals Dec 2012 |
| Medicrea |
Acquired by Medtronic, Nov 2020 |
| Medimetrics |
Assets acquired by Progenity, Sep 2019 |
| MedImmune |
Acquired by AstraZeneca, Apr 2007, $15.6B; folded into AstraZeneca, Feb 2019 |
| Medion Diagnostics |
Bought by Grifols? |
| Medistem |
Bought by Intrexon Dec 2013 |
| Medivation |
Bought by Pfizer, Oct 2016, $14B |
| Medivative Technologies |
Acquired by Kimball Electronics, Jul 2016 |
| Medivators |
Acquired by Cantel Medical, Sep 2015 |
| MedPharmics |
Acquired by Velocity Clinical, Sep 2022 |
| MedPlast |
Bought Integer Business & Rebranded as Viant Medical, Jul 2018 |
| Medpointe Pharmaceuticals |
Acquired by Meda Aug 2007, $767M |
| MedShape |
Acquired by DJO, Apr 2021 |
| MedSource |
Acquired by Ergomed, Dec 2020, $18M |
| Medtech |
Acquired by Zimmer Biomet, Jul 2016 |
| MEDTOX |
Bought by Labcorp Jul 2012 |
| Medventure |
Acquired by Helix Medical, Oct 2012 |
| MeiRui Pharma |
Bought by GSK |
| Melanovus Oncology |
Assets acquired by Cipher Pharmaceuticals, Jan 2015 |
| Memory Pharmaceuticals |
Acquired by Roche, Nov 2008 |
| Mera Pharmaceuticals |
Bought by a karate business, Aug 2012, presumably for ticker |
| Meraqi Medical |
Acquired by Viant Medical, Sep 2019 |
| Merial |
Acquired by Sanofi 2009, swapped to Boehringer Ingelheim Jun 2016 |
| Meridian BioGroup |
Acquired by Pace Life Sciences, Aug 2022 |
| Meridian Medical Technologies |
Merged into Kindeva, Dec 2022; Acquired by Altaris, Dec 2021 |
| Meridien Research |
Acquired by Accel Clinical Research, Jun 2020 |
| Meritage Pharma |
Bought by Shire, Feb 2015, $70M +$175 milestones |
| Merus Labs |
Bought by Norgine, Jul 2017, $342M |
| Mesa Biotech |
Acquired by Thermo Fisher, Mar 2021, $550M |
| Metabasis |
Bought by Ligand |
| Metaphore Pharmaceuticals |
Acquired by ActivBiotics, Jan 2006 |
| MethylGene |
Bought by Mirati Therapeutics Jun 2013 |
| Metrics Contract Services |
Acquired by Catalent, Aug 2022, $475M |
| Metys Pharmaceuticals |
Acquired by Novaremed, Sep 2021 |
| MGI Pharma |
Acquired by Eisai, Jan 2008, $3.9B |
| MiaMed |
Bought by Amicus Therapeutics, Jul 2016, $6.5M cash/stock + $85M milestones |
| Michrom |
Bought by Bruker, Feb 2011, |
| Microbiology Research Associates |
Acquired by private equity, combined into Analytical Lab Group |
| Microchips Biotech |
Acquired by Dare Bioscience Nov 2019; fka microCHIPS inc |
| MicroConstants |
Acquired by BioAgilytix, Aug 2021 |
| MicroDose Therapeutx |
Bought by Teva, Jun 2013, $40M + $125 milestones |
| MicroMed Laboratories |
Acquired by Infinity Laboratories, Jun 2020 |
| Micromet |
Bought by Amgen Jan 2012, $1.2B |
| Microsulis Medical |
Acquired by AngioDynamics, 2013 |
| Microtest |
Acquired by Accuratus Lab Services, Jul 2014 |
| Micrus Endovascular |
Bought by J&J, Sep 2010 |
| Middle Peak Medical |
Acquired by Symetis, technology moved to Polares Medical |
| MiddleBrook Pharmaceuticals |
Bought by Victory Pharmaceuticals 2011 |
| MIDI Labs |
Acquired by Biolog, Jan 2023 |
| Midlothian Labs |
Acquired by Hi-Tech Pharmacal, Dec 2007 |
| MIGS |
Acquired by DNA2.0, Apr 2016, |
| Miikana Therapeutics |
Acquired by Entremed, Jan 2006 |
| Millennium Pharmaceuticals |
Acquired by Takeda, May 2008, $8B, eventually rebranded as Takeda Oncology |
| Millipede Medical |
Bought by Boston Scientific, Feb 2019, $325M |
| MirImmune |
Acquired by Rxi Pharma, Jan 2017, stock |
| MiroBio |
Acquired by Gilead, Sep 2022 |
| Misonix |
Acquired by Bioventus, Oct 2021, $518M |
| Mitim |
Acquired by Recipharm, Feb 2016, $75.5M |
| MitoKor |
Bought by Micrologix Biotech Apr 2004 |
| Mitosciences |
Acquired by Abcam, May 2011, $6M |
| MJ Geneworks |
Acquired by Bio-Rad, Aug 2004, $32M |
| MMI Genomics |
Assets bought by Neogen |
| Mo Bio Laboratories |
Acquired by Qiagen, Jan 2016 |
| Mobius Imaging |
Bought by Stryker, Oct 2019, $500M |
| MockV Solutions |
Acquired by Maravai LifeSciences, Mar 2020 |
| ModeX Therapeutics |
Acquired by OPKO Health, May 2022, $300M |
| ModiQuest |
Acquired by ImmumoPrecise, Apr 2018 |
| Modis Therapeutics |
Bought by Zogenix, Sep 2019, $250M + $150M milestones |
| Molecular Infusions |
Acquired by Surterra Wellness |
| Molecular Insight Pharmaceuticals |
Acquired by Progenics, Jan 2013 |
| Molecular Medicine |
Acquired by AGC Biologics, Sep 2021; aka MolMed |
| Molecular Medicine Bioservices |
Acquired by SAFC |
| Molecular Profiles |
Acquired by Columbia Labs, Sep 2013 |
| Molecular Response |
Acquired by Bioduro, Mar 2018 |
| MolecularMD |
Acquired by ICON plc, Feb 2019 |
| Mologic |
Acquired by Gates & Soros and turned into nonprofit |
| MoMelan Technologies |
Acquired by Kinetic Concepts, Nov 2012 |
| Momenta Pharmaceuticals |
Acquired by J&J, Oct 2020, $6.5B |
| Monogram Biosciences |
Bought by LabCorp 2009 |
| Montigen Pharmaceuticals |
Acquired by SuperGen, Apr 2006, $18M |
| Montis Pharmaceuticals |
Bought by SuperGen, Apr 2006 |
| Morphochem |
Acquired by Deinove, May 2018 |
| Morphogen-IX |
Acquired by Centessa Pharmaceuticals |
| Morphotek |
Acquired by Eisai, Apr 2007 |
| Morton Grove Pharmaceuticals |
Acquired by Wockhardt, Oct 2007 |
| Motus Therapeutics |
Bought by Allergan, Oct 2016, $200M |
| Mpex Pharmaceuticals |
Acquired by Axcan 2011, $17.5M + $195M milestones |
| MPI Research |
Acquired by Charles River Laboratories, Apr 2018, $800M |
| MultiGEN Diagnostics |
Bought by PCLS Apr 2014 |
| Multiplicom |
Acquired by Agilent, €68M, Dec 2016 |
| MVI Health |
Acquired by Penumbra, Sep 2018 |
| MVP Laboratories |
Acquired by Phibro Animal Health, Jan 2016 |
| MWG Biotech |
Owned by Eurofins |
| Myogen |
Acquired by Gilead, Oct 2006, $2.5B |
| MyoKardia |
Acquired by Bristol-Myers Squibb, Oct 2020, $13.1B |
| Myonexus Therapeutics |
Bought by Sarepta, May 2019, $165M |
| MYR Pharmaceuticals |
Acquired by Gilead, Mar 2021, €1.1B + €300M milestones |
| Myraqa |
Acquired by Illumina Jul 2014 |
| N-of-One |
Acquired by Qiagen, Jan 2019 |
| Nalpropion Pharmaceuticals |
Bought by Currax, Sep 2019 |
| Nano Science |
Acquired by EAG, 2006 |
| Nano3D Biosciences |
Assets sold to Greiner Bio-One, May 2018 |
| Nanolabz |
Acquired by HIL Applied Medical, Jun 2016 |
| nanoMR |
Bought by DNA electronics, Jan 2015, $24M |
| Nanopareil |
Acquired by Gamma Biosciences, Sep 2020 |
| Nanosphere |
Acquired by Luminex, Jun 2016 |
| Nanostim |
Acquired by St. Jude Medical, Octo 2013 |
| NanoView Biosciences |
Acquired by Unchained Labs, May 2022; Merged with Nexgen Arrays, Dec 2016 |
| Narus Biotechnologies |
Acquired by Cofactor Genomics, Feb 2016 |
| NAT Diagnostics |
Acquired by Becton-Dickinson, May 2020 |
| Natrix Separations |
Acquired by Merck KGaA/MilliporeSigma, Aug 2017 |
| Nature Technology |
Acquired by Aldevron, Jan 2022 |
| Naurex |
Acquired by Allergan, Jul 2015, $560M + milestones |
| Navigenics |
Acquired by Life Technologies 2012 |
| NBE Therapeutics |
Acquired by Boehringer Ingelheim, Dec 2020, €1.18B |
| nContact |
Bought by AtriCure $99M, Oct 2015 |
| Negma Labs |
Bought by Wockhardt, May 2007, $265M |
| Nemod Biotherapeutics |
Assets bought by Glycotope Biotechnology 2007 |
| NeoGenesis Pharmaceuticals |
Assets acquired by Schering-Plough, Jan 2005 |
| Neomend |
Acquired by Bard, Oct 2012, $140M |
| Neon Therapeutics |
Acquired by BioNTech, May 2020, $67M |
| Neox Clinical Research |
Acquired by Emmes, Dec 2020 |
| Neuavi |
Acquired by Codman Neuro, Apr 2017 |
| Neugenesis |
Bought by Intrexon, 2011 |
| Neuravi |
Acquired by J&J, Apr 2017 - Became part of Cerenovus |
| Neuro Kinetics |
Acquired by Neurolign, Oct 2019 |
| Neuro3d |
Acquired by Evotec, Mar 2007 |
| NeuroCycle Therapeutics |
Acquired by Engrail Therapeutics, Feb 2021 |
| Neurogen |
Acquired by Ligand Pharmaceuticals 2009 |
| Neuronex |
Acquired by Acorda Therapeutics, Dec 2012, $6.8M |
| NeuroNova |
Acquired by Newron, Jun 2012 |
| NeuroTherm |
Bought by St Jude Medical Aug 2014, $200M |
| Neurovance |
Acquired by Otsuka Pharmaceuticals, Mar 2017, $100M + $150M milestones; Euthymics spinout |
| NeuWave Medical |
Bought by Ethicon, Mar 2016 |
| New River Pharmaceuticals |
Acquired by Shire, Apr 2007, $2.6B |
| NewLink Genetics |
Acquired by Lumos Pharma in Reverse Merger, Mar 2020 |
| Nexa Orthopedics |
Acquired by Tornier, Feb 2007 |
| Nexgen Pharma |
Acquired by LGM Pharma, Jul 2020 |
| NextBio |
Acquired by Illumina, Oct 2013 |
| NextCODE Health |
Acquired by WuXi PharmTech, Jan 2015, $65M; rebranded as WuXi NextCODE |
| Nextwave Pharmaceuticals |
Bought by Pfizer Oct 2012; Sold to Tris Pharma Sep 2018 |
| Nexus Biosystems |
Acquired by Brooks, Jul 2011 |
| Nexus Therapeutics |
Acquired by Transport Pharmaceuticals, Aug 2006 |
| Nexvet |
Acquired by Zoetis, Jul 2017, $85M |
| Nightstar Therapeutics |
Acquired by Biogen, Jun 2019, $800M; aka NightstaRx |
| Nigra |
Acquired by Vernalis |
| Nimbic Systems |
Acquired by Mizuho OSI, Sep 2020 |
| NimbleGen |
Bought by Roche, renamed Roche Nimblegen, some tech sold to Arrowhead |
| Nine Continents Medical |
Acquired by Coloplast, Oct 2020, $145M |
| NitroMed |
Bought by private equity company, Jan 2009, effectively dissolved; Sole drug sold on to Arbor Pharmaceuticals, 2012 |
| Nogra Pharma |
Bought by Celgene, Apr 2014, $710M |
| Noria Therapeutics |
Acquired by Bayer, Jun 2021 |
| Norphan Pharmaceuticals |
Acquired by Marathon Pharmaceuticals, 2013 |
| Northern Biologics |
All products acquired as of Nov 2020 |
| NovaCardia |
Bought by Merck, Jul 2007, $350M |
| Novacea |
Bought by Transcept |
| Novadaq |
Bought by Stryker, Sep 2017 |
| Novalon Pharmaceutical |
Acquired by Karo Bio Nov 2000 |
| Novartis Animal Health |
Acquired by Lilly |
| NovaScreen Biosciences |
Acquired by Caliper Life Sciences, Oct 2005, $22M |
| NovaTarg Therapeutics |
Acquired by Pano Therapeutics, Apr 2022 |
| Novatract Surgical |
Acquired by Caldera Medical, 2016 |
| Novavita Thera |
Acquired by Castle Creek Biosciences, Jan 2022 |
| Novella Clinical |
Acquired by Quintiles, Sep 2013 |
| NOVEX |
Acquired by Thermo-Fisher, Aug 1999, stock |
| Novex Clinical Research |
Acquired by BTC Network, Aug 2016 |
| Novira Therapeutics |
Bought by J&J, Nov 2015, |
| Novosis |
Acquired by Acino, 2006 |
| Novosteo |
Acquired by Cortexyme, May 2022 |
| NPS Pharmaceuticals |
Acquired by Shire, Jan 2015, $5.2B |
| Nucleo Life Sciences |
Acquired by CoreRx, May 2021 |
| Nucleus Therapeutics |
Acquired by Patrys, Aug 2016 |
| Nucryst |
Bought by Smith & Nephew |
| Nuevolution |
Bought by Amgen May 2019 |
| NuGEN Technologies |
Acquired by Tecan, Aug 2018, $54.4M |
| NuPak Medical |
Bought by Katena Products, Jul 2017 |
| NuPathe |
Bought by Teva, Jan 2014, $144M |
| Nura |
Acquired by Omeros |
| NuVera Medical |
Acquired by Biosense Websiter, Sep 2021 |
| nVision Medical |
Acquired by Boston Scientific, Apr 2018, $275M |
| NxThera |
Acquired by Boston Scientific, Apr 2018, $306M + $100M milestones |
| Nycomed |
Acquired by Takeda 2011 |
| OBP Medical |
Acquired by CooperSurgical, May 2021, $60M |
| Obsidio |
Acquired by Boston Scientific, Aug 2022 |
| Ocata Therapeutics |
Acquired by Astellas, Jan 2016, $379M; fka Advanced Cell Technology |
| Ocean Ridge Biosciences |
Acquired by Frontage, Apr 2021 |
| Oceana Therapeutics |
Acquired by Salix Pharmaceuticals, Nov 2011, $300M |
| OcellO |
Acquired by Crown Bioscience, May 2021 |
| Ocera Therapeutics |
Acquired by Mallinckrodt, Dec 2017, $42M |
| Ockham |
Acquired by Chiltern, Jul 2014 |
| Oclassen Pharmaceuticals |
Acquired by Watson Pharmaceuticals, Feb 1997 |
| Octagen |
Assets bought by Ipsen, 2008 |
| Octoplus |
Acquired by Dr. Reddy's, 2013, $36M |
| Oculeve |
Bought by Allergan, Jul 2015, $125M |
| Oculex Pharmaceuticals |
Acquired by Allergan, Oct 2003 |
| Oculos Clinical Research |
Acquired by iuvo BioScience, Jul 2018 |
| Ogeda |
Bought by Astellas, May 2017, €500M |
| Ohm Laboratories |
Owned by Ranbaxy, then Sun Pharma |
| Ohr Pharmaceuticals |
Acquired by NeuBase Therapeutics via Reverse Merger, Jul 2019 |
| Okairos |
Acquired by GSK, May 2013 |
| Okapi Sciences |
Acquired by Aratana Therapeutics, Jan 2014 |
| Ology Bioservices |
Acquired by Resilience, Apr 2021 |
| OMBU Bio |
Assets acquired by Boca Biolistics, Feb 2015 |
| Omega Pharma |
Acquired by Perrigo, Mar 2015 |
| Omni-Tract Surgical |
Acquired by Integra LifeSciences, Jan 2009 |
| OmniGene Bioproducts |
Acquired by BioEnergy |
| OMNILife Sciences |
Acquired by Corin Group, Mar 2019 |
| Omniome |
Acquired by Pacific Biosciences, Sep 2021, $800M |
| Omrix Biopharmaceuticals |
Bought by Ethicon |
| Omthera Pharmaceuticals |
Bought by AstraZeneca, May 2013, $323M |
| On-X Life technologies |
Acquired by CryoLife, Jan 2016, $130M |
| Oncoceutics |
Acquired by Chimerix, Jan 2021, $78M |
| Oncodisc |
Acquired by Veris Health, Jun 2021 |
| OncoEthix |
Acquired by Merck, Dec 2014, $375M |
| Oncogen |
Acquired by BMS, 1986 |
| Oncogene Science |
Acquired by Nuclea Biotechnologies |
| OncoImmune |
Acquired by Merck, Nov 2020, $425M |
| OncoPlexDx |
Bought by Nantomics, Oct 2016 |
| Oncos Therapeutics |
Acquired by Oncos Therapeutics, Jun 2015 |
| Oncoscope |
Assets acquired by SpectraScience, Feb 2016 |
| Oncotest |
Acquired by Charles River, Nov 2015, €34M |
| One Lambda |
Acquired by Thermo Fisher, Sep 2012 |
| Onset Dermatologics |
Acquired by Valeant Feb 2014 |
| Onspira Therapeutics |
Acquired by Altavant Sciences, Jan 2020 |
| Onux medical |
Acquired by Bard, Jul 2004 |
| Onyvax |
Assets Apparently Acquired |
| Onyx Pharmaceuticals |
Bought by Amgen, Aug 2013, $10.4B |
| Open Biosystems |
Acquired by Thermo-Fisher 2008 |
| Open Monoclonal Technology |
Acquired by Ligand, Jan 2016, $178M |
| Opiant Pharmaceuticals |
Acquired by Indivior, Mar 2023, $145M |
| Optima Neuroscience |
Acquired by Tucker-Davis Technologies, Sep 2011 |
| Optime Therapeutics |
Acquired by Lippomix |
| OptiMedica |
Acquired by Abbott Aug 2013, $400M |
| Optimer Pharmaceuticals |
Acquired by Cubist Oct 2013 |
| Optivia Biotechnology |
Acquired by BioIVT, Jul 2018 |
| Optometrics |
Acquired by Dynasil, Mar 2005 |
| Opus Medical |
Acquired By ArthroCare, Nov 2004, $130M |
| OPX Biotechnologies |
Acquired by Cargill, Apr 2015 |
| OraPharma |
Owned by Valeant |
| Oraya Therapeutics |
Absorbed into Zeiss, Jun 2016 |
| Orbis Biosciences |
Acquired by Adare Pharmaceuticals, May 2020 |
| Orchid Cellmark |
Acquired by LabCorp Dec 2011 |
| Orexia |
Acquired by Centessa |
| Organon |
Bought by Schering-Plough Nov 2007, integrated into Merck post 2009 acquisition |
| OriCiro Genomics |
Acquired by Moderna, Jan 2023, $85M |
| Oriel Therapeutics |
Bought by Sandoz, Jun 2010 |
| Origenix |
Acquired by Micrologix Biotech, Sep 2002, $320M |
| Origin BioMed |
Assets sold to Knight Therapeutics, Jun 2015 |
| Origo Biopharma |
Acquired by Agomab, Oct 2021 |
| Orphan Europe |
Acquired by Recordati, Sep 2007 |
| Orphan Technologies |
Acquired by Travere Therapeutics (Retrophin), Nov 2020, $90M + $427 Milestones |
| Orphazyme |
Acquired by kemPharm, May 2022, $7.6M |
| Ortho Clinical Diagnostics |
Acquired by Quidel, Dec 2021, $6B |
| Orthocon |
Assets Acquired by Abryx, Apr 2013 |
| Orthogonal Biologics |
Acquired by Cyrus Biotechnology, Dec 2021 |
| Orthosensor |
Acquired by Stryker, Jan 2021 |
| OrthoSpin |
Acquired by Depuy Synthes, Dec 2021 |
| Oscine Therapeutics |
Acquired by Sana Biotechnology, Oct 2020 |
| Oscor |
Acquired by Integer, Dec 2021 |
| OSI Pharmaceuticals |
Bought by Astellas |
| Osiris Therapeutics |
Acquired by Smith & Nephew, Apr 2019, $660M |
| OSO Biopharmaceuticals |
Acquired by AMRI, Jul 2014 |
| Osseon |
Dissolved, assets acquired by Merit medical, Sep 2014 |
| Ossis |
3D-printed orthopedic implants |
| Osteotech |
Acquired by Medtronic Aug 2010 |
| Othera Pharmaceuticals |
Acquired by Colby Pharmaceuticals 2012 |
| Ovation Pharmaceuticals |
Acquired by Lundbeck 2009 |
| Oxitec |
Bought by Intrexon, Aug 2015, $160M |
| Oxxon Therapeutics |
Acquired by Oxford Biomedica Mar 2007 |
| PAA Laboratories |
Acquired by GE Healthcare, Aug 2011 |
| Pacific Bio-Material Management |
Acquired by Brooks Life Sciences, Jul 2017 |
| PacificGMP |
Bought by Abzena, Sep 2015, $8.4M |
| Paddock Labs |
Bought by Perrigo Jan 2011 |
| Padlock Therapeutics |
Acquired by BMS, Mar 2016, $225 + $375 milestone |
| Paganini Biopharma |
Bought by OncoResponse, Nov 2017 |
| Paidion Research |
Acquired by Premier Research, May 2021 |
| PAIRimmune |
Acquired by Pacific Biomarkers, Jun 2019 |
| Paloma Pharmaceuticals |
Acquired by Stratus Media, Renamed RestorGenex, Mar 2014 |
| PAN Medical |
Bought by Zavation, Sep 2018 |
| Pandion Therapeutics |
Acquired by Merck, Feb 2021, $1.85B |
| Pangenetics |
Bought by Abbott |
| Panoptes Pharma |
Acquired by EyeGate Pharmaceuticals, Jan 2021 |
| Panther Biotechnology |
Acquired in Reverse Merger by media company, presumably for ticker symbol |
| Paradigm Diagnostics |
Acquired by Exact Sciences, Mar 2020 |
| Paradigm Spine |
Acquired by RTI Surgical, Mar 2019 |
| Paragon Bioservices |
Acquired by Catalent, May 2019, $1.2B |
| Parallax Medical |
Acquired by ArthroCare, Jan 2004, $35M; Sold to NeuroTherm, Jul 2011 |
| Parcus Medical |
Acquired by Anika Therapeutics, Jan 2020, $35M + $60M milestones |
| Park Therapeutics |
Acquired by Tris Pharma, Apr 2021 |
| Parsagen Diagnostics |
Acquired by Qiagen |
| Particle Sciences |
Acquired by Lubrizol |
| PathoGenesis |
Acquired by Chiron, 2000, $600M |
| Pathway Medical |
Acquired by Bayer, Aug 2011, $125M |
| Pathway Oncology |
Acquired by Virax, Mar 2014 |
| PaxVax |
Acquired by Emergent Biosolutions, Oct 2018, $270M |
| PCT Cell Therapy |
Acquired by Hitachi, Mar 2017, $75M, rebranded as Hitachi Chemical Advanced Therapeutics Solutions |
| Pearl Therapeutics |
Acquired by AstraZeneca Jul 2013, $560M+$450milestones |
| PegaOne |
Centessa Company |
| Pegasus Biologics |
Assets acquired by Synovis Life Technologies, Jul 2009 |
| Pelican Therapeutics |
Bought by Heat Biologics, Mar 2017 |
| Peloton Therapeutics |
Bought by Merck, May 2019, $1.05B + $1.2B Milestones |
| Pelvalon |
Acquired by Laborie, Oct 2021 |
| Peninsula Pharmaceuticals |
Acquired by Ortho-McNeil, Apr 2005 |
| Penn Pharma |
Bought by PCI Pharma Services, Jul 2014, $215M |
| Penwest |
Bought by Endo |
| Peplin |
Acquired by Leo Pharma 2009 |
| PepSep |
Acquired by Bruker, Feb 2022 |
| Perbio Science |
Acquired by Fisher Scientific, Jun 2003 |
| PermeaDerm |
Acquired by Stedical Scientific, Aug 2019 |
| Perosphere Pharmaceuticals |
Acquired by AMAG Pharmaceuticals, Jan 2019 |
| Perseid Therapeutics |
Bought by Astellas May 2011 |
| Perseon Medical |
Assets bought by Medlink, Aug 2016, $4M; fka BSD Medical |
| PerSeptive Biosystems |
Acquired by Perkin-Elmer, 1998 |
| Pervasis |
Bought by Shire, Sep 2009 |
| Pervasis Therapeutics |
Bought by Shire 2012 |
| Pfenex |
Acquired by Ligand, Oct 2020, $437.5M + $78M milestone; Spun out of Dow Chemical 2009 |
| PFS Genomics |
Acquired by Exact Sciences, May 2021, $30.6M |
| Phadia |
Acquired by Thermo Fisher, May 2011, $3.5B |
| PhagoMed |
Acquired by BioNTech, Nov 2021 |
| PharmaCell |
Acquired by Lonza, May 2017 |
| Pharmacopeia |
Acquired by Ligand Pharmaceuticals 2008 |
| Pharmacore |
Acquired by Cambrex, Sep 2016, $25M |
| Pharmacyclics |
Bought by AbbVie, $21B May 2015 |
| PharmaFluidics |
Acquired by Thermo Fisher, Oct 2021 |
| PharmaForm |
Bought by Biotech Investment Group, Relaunched as Formex Jul 2013 |
| PharmaKinetics Laboratories |
Acquired by BASi, Jun 2002? |
| PharmaSphere |
Acquired by Marijuna company, Nov 2011 |
| Pharmasset |
Bought by Gilead, Nov 2011, $11B |
| Pharmatek |
Acquired by Catalent, Sep 2016 |
| Pharmaterials |
Acquired by Quotient Sciences, Nov 2017 |
| Pharmavene |
Acquired by Shire, Mar 1997 |
| Pharmion |
Acquired by Celgene 2007 |
| Phase Forward |
Bought by oracle |
| Phenix Research Products |
Acquired by Thomas Scientific |
| Pherin Pharmaceuticals |
Acquired by Vistagen, Feb 2023 |
| Phitonex |
Acquired by Thermo Fisher, Jan 2021 |
| PhosImmune |
Acquired by Agenus, Dec 2015, up to $45M |
| Phosphagenics |
Renamed Avecho Biotechnology |
| PHT Corporation |
Acquired by ERT, May 2015 |
| PhyNexus |
Acquired by Biotage, Jan 2019 |
| Physio-Control |
Bought by Stryker, Feb 2016, $1.28B - became Stryker Emergency Care |
| Phytera |
Assets sold to Galileo, Apr 2002 |
| Phytopharm |
Acquired by Ixico, Sept 2013 |
| Phyxius Pharma |
Assets acquired by Oxygen Therapeutics, Nov 2013, effectively merged |
| Pinewood |
Bought by Wockhardt, Feb 2013, €150M |
| Pinnacle Pharmaceuticals |
Acquired by New River Pharmaceuticals, 2011 |
| Piramed Pharma |
Acquired by Roche, Apr 2008, $160M + $15M milestones |
| Pivot Medical |
Bought by Stryker, Mar 2014 |
| Platine Pharma Services |
Bought by ABL inc, Jul 2014 |
| Plato BioPharma |
Acquired by Inotiv, Oct 2021, $15M |
| Plexxikon |
Acquired by Daiichi Sankyo, Feb 2011 |
| PML Microbiologicals |
Bought by Bimerieux Dec 2008 |
| PneumRx |
Acquired by BTG plc, Dec 2014, $475M |
| Pola Pharma |
Acquired by Sun Pharma, Jan 2019 |
| Porex Surgical |
Acquired by Stryker, Sep 2010 |
| PortaScience |
Acquired by DCN Dx, Jun 2021 |
| Portola Pharmaceuticals |
Acquired by Alexion Pharmaceuticals, Jul 2020, $1.4B |
| Potenza Therapeutics |
Bought by Astellas, Dec 2018 |
| PowderMed |
Acquired by Pfizer 2006 |
| Powervision |
Acquired by Alcon, Mar 2019, $285M |
| PQ Bypass |
Acquired by Thermo Fisher, Apr 2021, $17.4B |
| PRA Health Sciences |
Acquired by ICON plc., Jul 2021, $12B |
| PRAECIS Pharmaceuticals |
Acquired by GSK, Dec 2006, $54.8M |
| Praha Vaccines |
Acquired by Novavax, Jun 2020 |
| Praxis Life Sciences |
Acquired by Treximo, Mar 2019 |
| preCARDIA |
Acquired by Abiomed, Jun 2021 |
| Precision Healing |
Acquired by Sanara MedTech, Apr 2022 |
| PreClinOmics |
Acquired by Crown Bioscience, Mar 2016 |
| Pregenen |
Bought by bluebird bio Jun 2014 |
| PregLem |
Acquired by Richter, Oct 2010 |
| Prescient Neuropharma |
Acquired and renamed, pivoted to mining |
| Prexton Therapeutics |
Acquired by Lundbeck, Mar 2018, $123M |
| Primatope Therapeutics |
Acquired by Kiniksa, May 2019 |
| PrimeraDx |
Bought by Qiagen, Jun 2014 |
| Primity Bio |
Acquired by Caprion Biosciences, Sep 2018 |
| Primorigen Biosciences |
Acquired by Nucleus Biologics, Aug 2019 |
| Principia Biopharma |
Acquired by Sanofi, Sep 2020 |
| Prionics |
Acquired by Thermo Fisher, Mar 2014 |
| Prism Pharmaceuticals |
Acquired by Baxter 2011 |
| Prismic Pharmaceuticals |
Acquired by FSD Pharma, Jun 2019 |
| Prochon Biotech |
Acquired by Histogenics |
| ProCyte |
Acquired by PhotoMedex, Mar 2005 |
| ProEthic Laboratories |
Acquired by Kowa, Sep 2008 |
| ProFibrix |
Bought by The Medicines Company, Aug 2013, $90M + $140 milestones |
| Progen Pharmaceuticals |
Acquired by TBG Diagnostics, Jan 2016, Drug sold off to Zucero Therapeutics Aug 2016 |
| Progenics Pharmaceuticals |
Acquired by Lantheus, Jun 2020 |
| Progenika |
Bought by Grifols |
| Prolifaron |
Acquired by Alexion, Sep 2000, $41M |
| Prolor Biotech |
Acquired by OPKO, Aug 2013, renamed Opko Biologics |
| ProMedDx |
Acquired by Precision for Medicine, Aug 2019 |
| Promedior |
Acquired by Roche, Feb 2020 |
| Pronostics |
Assets acquired by Phadia, Jan 2009 |
| Pronova BioPharma |
Acquired by BASF, Jan 2013 |
| Pronovo Biopharma |
Bought by BASF, Nov 2012, $844M |
| Propeller Health |
Acquired by ResMed, Dec 2018, $225M |
| Prosensa |
Acquired by BioMarin, Nov 2014, $680M+milestones |
| Prosidion |
Bought by OSI pharmaceuticals, Apr 2005 |
| Prosonix |
Bought by Circassia, Jun 2015, $158M |
| Prostrakan |
Acquired by Kyowa Hakko Kirin; renamed Kyowa Kirin Apr 2016 |
| Protagen Diagnostics |
Acquired by Oncimmune, Mar 2019 |
| Protein Forest |
Bought by Cell Biosciences |
| Protein Sciences |
Acquired by Sanofi, Aug 2017, $650M + $100M milestones |
| ProteinSimple |
Bought by biotechne, Aug 2014, $300M |
| Protenium Clinical Research |
Acquired by Eligo Health Research, Jan 2019 |
| Proteolix |
Bought by Onyx Pharmaceuticals, Oct 2009, up to $851M |
| Proteom |
Acquired by Amura Ltd |
| Proteon Therapeutics |
Acquired by ArTara Therapeutics, Reverse Merger, Jan 2020 |
| Proteona |
Acquired by Singleron, Mar 2022 |
| Protez Pharma |
Bought by Novartis 2008, Closed 2010 |
| Protherics |
Bought by BTG plc, Sep 2008, £218M |
| Proven Process |
Acquired by NextPhase Medical Devices, May 2021 |
| Provista Diagnostics |
Acquired by Todos Medical Apr 2021; Acquired by Ascenda BioSciences, Jun 2019 |
| Proximagen |
Acquired by Upsher-Smith, Aug 2012; Originally spun out of King's College London |
| ProZyme |
Acquired by Agilent, Aug 2018 |
| PSMA Therapeutics |
Acquired by Bayer, Jun 2021 |
| Psyadon Pharmaceuticals |
Acquired by Emalex Biosciences, Aug 2018 |
| PsyCheNomicS |
Acquired by Novasite Pharmaceuticals, Jun 2005 |
| Pulsar Vascular |
Bought by J&J Jul 2017 - Became part of Cerenovus; Previously acquired by Codman Neuro, Dec 2016 |
| Pulse Systems |
Acquired by Heraeus, 2020 |
| Pursuit Vascular |
Acquired by ICU Medical, Nov 2019, $75M |
| Putney |
Acquired by Dechra, Mar 2016 |
| PvP Biologics |
Bought by Takeda, Feb 2020, up to $330M |
| PX' Therapeutics |
Acquired by Promise Proteomics, Jul 2019 |
| Qrumpharma |
Acquired by MannKind, Dec 2020 |
| QS Pharma |
Acquired by Quotient Clinical, 2017 |
| Quad Technologies |
Acquired by Bio-techne, Jun 2018 |
| Quadrants Scientific |
Acquired by Infinity Laboratories |
| Qualyst |
Acquired by BioIVT, Sep 2017 |
| Quanam Medical |
Acquired by Boston Scientific, Apr 2001, $8M |
| QuantaLife |
Acquired by Bio-Rad, Oct 2011, $162M |
| Quanticel Pharmaceuticals |
Acquired by Celgene, $100M +$300M milestones, Apr 2015 |
| Quantum Pharma |
Acquired by Clinigen, Nov 2017 |
| Quartesian |
Acquired by Veranex, Jun 2021 |
| QuatRx |
Acquired by Shionogi, 2017 |
| Quellis Biosciences |
Acquired by Catabasis Pharmaceuticals, Jan 2021 |
| Questcor Pharmaceuticals |
Acquired by Mallinckrodt, Aug 2014 $5.8B |
| Quethera |
Bought by Astellas, Aug 2018, up to $109M |
| Quotient Bioresearch |
Acquired by Pharmaron, Feb 2016 |
| R-Tech Ueno |
Acquired by Sucampo, Aug 2015, $276B |
| Ra Pharmaceuticals |
Bought by UCB, Apr 2020, $2.1B |
| Radiant Genomics |
Acquired by Zymergen, Jan 2018 |
| RadioTherapeutics |
Acquired by Boston Scientific, Nov 2001, $150M |
| Raindance Technologies |
Acquired by Bio-Rad, Jan 2017 |
| Raptor Pharmaceuticals |
Acquired by Horizon Pharma, Oct 2016, $800M |
| Rare Thyroid Therapeutics |
Acquired by PledPharma, Oct 2020 |
| RareGen |
Acquired by Liquidia, Jun 2020 |
| Raven Biotechnologies |
Acquired by MacroGenics Jul 2008 |
| RCP Diagnostics |
Acquired by Provista Life Sciences, Dec 2006 |
| ReadCoor |
Acquired by 10X Genomics, Oct 2020 |
| Realm Therapeutics |
Acquired by ESSA Pharma, Jul 2019; fka PuriCore, abandoned all clinical work Sep 2018, seems to be wound care/topical 510(k) products |
| Rebound Therapeutics |
Bought by Integra LIfeSciences, Sep 2019 |
| Receptos |
Bought by Celgene, Jul 2015, $7.2B |
| RedoxTherapies |
Acquired by Juno, Jul 2016, $10M + milestones |
| Redwood Bioscience |
Acquired by Catalent, Oct 2014 |
| Reflectance Medical |
Acquired by Sotera, Feb 2015 |
| Regulatory Professionals, Inc. |
Acquired by Premier Research, Jul 2018 |
| Regulus Pharmaceutical Consulting |
Acquired by Clinipace |
| Reinnervate |
Acquired by ReproCELL, combined with Biopta to become ReproCELL Europe, Jul 2016 |
| Reliable Biopharmaceutical |
Bought by VWR Nov 2016 |
| Relypsa |
Bought by Galenica, Jul 2016, $1.5B, became part of Vifor |
| Rempex Pharmaceuticals |
Acquired by The Medicines Company Dec 2013, $140M |
| RenaMed Biologics |
Assets sold to Nephrion, 2007 |
| Renovacor |
Acquired by Rocket Pharmaceuticals, Dec 2022; Went public via SPAC Sep 2021 |
| Reproductive Health Science |
Acquired by Perkin-Elmer, Jul 2018 |
| Reprogenetics |
Acquired by CooperSurgical, Jun 2016 |
| Repros Therapeutics |
Acquired by Allergan, Dec 2017 |
| Research Across America |
Acquired by Synexus, Mar 2016 |
| Research Diagnostic, Inc. |
Acquired by Fitzgerald Industries, 2005 |
| ReSearch Pharmaceutical Services |
Acquired by PRA, renamed RPS Strategic Solutions Division |
| ReShape Medical |
Acquired by EnteroMedics, Oct 2017 |
| Respicardia |
Acquired by Zoll, Apr 2021 |
| Respironics |
Bought by Philips, Mar 2008, $5.1B |
| RespiVert |
Acquired by Centocor Jun 2010 |
| Response Genetics |
Acquired by Cancer Genetics, Aug 2015 |
| Retrogenix |
Acquired by Charles River Labs, Mar 2021 |
| RetroSense Therapeutics |
Bought by Allergan, Sep 2016, $60M |
| Revascular Therapeutics |
Acquired by Boston Scientific, Feb 2011 |
| Reverse Medical Corp |
Bought by Covidien, 08/14 |
| ReViral |
Acquired by Pfizer, Jun 2022, up to $525M |
| Revivicor |
Acquired by United Therapeutics, 2011, $7.6M |
| Revolutionary Medical Devices |
Acquired by Vyaire, Oct 2017 |
| RF Surgical Systems |
Bought by Medtronic, Jul 2015, $235M |
| RHEINCELL Therapeutics |
Acquired by Catalent, Jun 2021 |
| RhoVac |
Reverse Merged with Chosa, Jan 2023 |
| Rhythm Xience |
Acquired by Acutus Medical, May 2019 |
| Ribonomics |
Sold to MBL International |
| Richcore Lifesciences |
Acquired by Laurus Labs, Jan 2021 |
| Riemser Pharma |
Acquired by Esteve, Jan 2020 |
| Rigenerand |
Acquired by Evotec, Jul 2022, €23M |
| Rigontec |
Bought by Merck, Sep 2017, $150M + $453 Milestones |
| Rinat |
Bought by Pfizer 2006 |
| Rio Grande Neurosciences |
Assets sold to Endonovo Therapeutics, Dec 2017, $4.5M |
| RITA Medical Systems |
Bought by AngioDynamics 2007 |
| River Vision Development Corp |
Acquired by Horizon Pharma, May 2017, $145M |
| rMark Bio |
Acquired by Within3, Apr 2021 |
| RND Group |
Acquired by Gener8, Dec 2021 |
| Rodeo Therapeutics |
Acquired by Amgen, Apr 2021, $55M + $666 milestones |
| Rodin Therapeutics |
Acquired by Alkermes, Nov 2019, up to $950M |
| Rosetta Inpharmatics |
Bought by Merck 2001 |
| Rotation Medical |
Bought by Smith & Nephew, Oct 2017 |
| Roush Life Sciences |
Assets purchased by Foxx Life Sciences, 2011 |
| Roxane Labs |
Acquired from Boehringer-Ingleheim by Hikma, Feb 2016, merged into West-Ward Laboratories |
| Roxro Pharma |
Acquired by Luitpold 2010 |
| Roxwood Medical |
Acquired by BTG plc, Oct 2017 |
| RPS Diagnostics |
Assets acquired by Quidel, May 2017, $14M, shell merged into Lumos Diagnostics, May 2019 |
| RQX Pharmaceuticals |
Acquired by Amgen, Feb 2013, $111M |
| RTS Life Science |
Bought by Brooks Automation Apr 2011 |
| Rubicon Genomics |
Acquired by Takara, Jan 2017 |
| Rules-Based Medicine |
Acquired by Myriad Genetics, Apr 2011, $80M; rebranded Myriad-RBM |
| Safis Solutions |
Acquired by Pharmalex, Apr 2017 |
| SAGE Labs |
Acquired by Horizon Discovery, $48M, Sep 2014 |
| Salgomed |
Shut down Apr 2022 |
| SalvaRx |
Bought by Portage Biotech, Aug 2018 |
| Sanarus |
Acquired by Hologic, 2020 |
| Sandstone Diagnostics |
Assets acquired by Labcorp |
| Sanomune |
|
| Santaris Pharma |
Bought by Roche, Aug 2014 |
| Santarus |
Acquired by Salix Pharmaceuticals, Jan 2014 |
| Sapphire Biotech |
Acquired by AXIM Biotechnologies, Jan 2020 |
| Sapphire Therapeutics |
Acquired by Helsinn 2009 |
| SARcode |
Bought by Shire Mar 2013 |
| Satiogen Pharmaceuticals |
Acquired by Mirum Pharmaceuticals, May 2022 |
| Satoris |
Bought by Rules-Based Medicine |
| Savage Laboratories |
Was part of Fougera which was acquired by Sandoz, Jul 2012 |
| ScalmiBio |
Acquired by ALX Oncology, Oct 2021 |
| Scandipharm |
Bought by Axcan Pharma, $100M |
| Scendia Biologics |
Acquired by Sanara MedTech |
| Schein Pharmaceutical |
Acquired by Watson Pharmaceuticals, Aug 2000, $674M |
| Schering-Plough |
Acquired by Merck, Nov 2009 |
| Schwartz Pharma |
Acquired by UCB, 2006, €4.4B |
| Schwarz Pharma Manufacturing |
Acquired by UCB 2006 |
| Scidera Genomics |
Bought by Neogen, Jan 2013 |
| Sciele Pharma |
Bought by Shionogi |
| Sciformix |
Acquired by LabCorp, Jun 2018 |
| SciGen |
Bough by Yifan Pharmaceutical, Aug 2018 |
| Scil Technology |
Acquired by Nanohale, Sep 2012, creating subsidiary Formycon |
| Scioderm |
Bought by Amicus Aug 2015, $229M+$618M milestones |
| Scios |
Bought by JnJ, Feb 2003 |
| SciSafe |
Acquired by Biolife Solutions, Sep 2020 |
| SCM Pharma |
Taken over by Shire, Aug 2014 |
| Sea Lane Biotechnologies |
Assets acquired by i2 Pharmaceuticals, May 2017 |
| Seahorse Bioscience |
Acquired by Agilent, Nov 2015 |
| SeaView Research |
Acquired by Quotient Clinical, Feb 2017 |
| Securus Medical |
Bought by Boston Scientific, Apr 2018, $40M |
| Segetis |
Assets bought by GFBiochemicals, Feb 2016 |
| SegWay Orthopedics |
Acquired by Trice Medical, Feb 2019 |
| Select ImmunoGenomics |
Acquired by GeneCentric Therapeutics, Aug 2019 |
| Selexys |
Bought by Novartis, Nov 2016, $665M |
| Semba Biosciences |
Acquired by Tosoh Biosciences, Oct 2021 |
| Semma Therapeutics |
Acquired by Vertex, Sep 2019, $950M |
| Semprus Biosciences |
Acquired by Teleflex Jun 2012 |
| Senorx |
Acquired by Bard, May 2010, $200M |
| Sense Proteomics |
Acquired by Oxford Gene Technology, Mar 2009 |
| Sensile Medical |
Acquired by Gerresheimer, Jul 2019, up to €350M |
| Sentrx |
Bought by Telerx, Apr 2013 |
| SeqRight |
Acquired by GE Apr 2012 |
| Sequana Therapeutics |
Bought by Arris Pharmaceuticals 1998 |
| Sequenom |
Bought by LabCorp, Sep 2016, $371M |
| Sequenta |
Acquired by Adaptive Biotechnologies, Jan 2015 |
| Seragon Pharmaceuticals |
Acquired by Genentech, Aug 2014 $725M + $1B Milestones; Acquired by JNJ Aug 2013 $650M + $350 Milestones |
| Serametrix |
Acquired by Caprion Biosciences, Apr 2019 |
| Serendex Pharmaceuticals |
Bought by Savara Pharmaceuticals, Jun 2016 |
| Serenity Pharmaceuticals |
Acquired by Acerus, Mar 2022 |
| Serica Technologies |
Bought by Allergan |
| Serono Laboratories |
Acquired by Merck KGaA, 2006 |
| Sestina Bio |
Acquired by Inscripta, Jan 2023 |
| SeylanMED |
Acquired by DermBiont, Oct 2020 |
| SGM Biotech |
Acquired by Mesa Biotech, Apr 2010 |
| SGX Pharma |
Acquired by Eli Lilly Jul 2008 |
| Shantha Biotech |
Acquired by Sanofi, Jul 2009, $784M |
| Shenandoah Biotechnology |
Acquired by Fujifilm Irvine Scientific, Mar 2022 |
| Sherpa Clinical |
Acquired by PCI Pharma Services, Oct 2018 |
| Shire |
Bought by Takeda, Jan 2019, $62B |
| Shutt Medical Technologies |
Acquired by CONMED, 1983 |
| Sicor Biotech |
Bought by Teva 2004 |
| Sierra Oncology |
Acquired by GSK, Jul 2022, $1.9B |
| SIG Medical |
Acquired by Zimmer, Sep 2019 |
| Sigma-Aldrich |
Bought by Merck KgAA, Sep 2014, $17B, now part of MilliporeSigma |
| Silarx Pharmaceuticals |
Acquired by Lannett, Jun 2015 |
| Silene Biotech |
Acquired by NanoSurface Biomedical, Sep 2019 |
| Silicon Therapeutics |
Acquired by Roivant, Feb 2021, $450M |
| Siloam Biosciences |
Acquired by MiCo BioMed, May 2018 |
| Silvergate Pharmaceuticals |
Acquired by cutisPharma, Jun 2019 |
| SimplicityBio |
Acquired by Precision for Medicine, Mar 2019 |
| Simplify Medical |
Acquired by NuVasive, Feb 2021, $150M |
| Sinensis Life Sciences |
Acquired by eurofins, Jan 2016 |
| Singular Bio |
Acquired by Invitae, Jun 2019 |
| Sirius Analytical |
Acquired by pion, May 2017 |
| Sirna Therapeutics |
Bought by Merck 2006, Sold to Alnylam Jan 2012 |
| Sirtris Pharmaceuticals |
Acquired by GSK Apr 2008, Subsumed Mar 2013 |
| Sitari Pharmaceuticals |
Acquired by GSK, Sep 2019 |
| Skeletech |
Acquired by MDS, Aug 2005 |
| SkinMedica |
Acquired by Allergan Dec 2012 ($350 million) |
| Skyland Analytics |
Acquired by IDBS, Nov 2021 |
| Slate Pharmaceuticals |
Bought by Actient Pharmaceuticals Dec 2011 |
| Sloning Biotechnology |
Bought by MorphoSys, Oct 2010, $26.5M |
| SmartCells |
Bought by Merck Dec 2010 |
| Smith Therapeutics |
Acquired by AZTherapies, Oct 2019 |
| Smiths Medical |
Acquired by ICU Medical, Jan 2022, $2.35B |
| SNBL |
Acquired by Altasciences |
| SNBL CPC |
Acquired by Pharmaron, Feb 2017 |
| SOFAR surgical |
Acquired by TransEnterix, Sep 2015, $100M |
| Soin Therapeutics |
Acquired by JanOne, Sep 2022 |
| Solana Biosciences |
Acquired by Inscripta, Sep 2018 |
| Solentim |
Acquired by Advanced Instruments, Aug 2021 |
| Solid Form Solutions |
Acquired by Avista Pharma, Jan 2018 |
| SoloHill Engineering |
Acquired by Pall, Mar 2014 |
| Solstice Neurosciences |
Acquired by US World Meds 2010 |
| Solsys Medical |
Acquired by Misonix, Sep 2019, $97M stock; fka Soluble Systems |
| Solta Medical |
Acquired by Valeant, $236M Dec 2014 |
| Soluble Therapeutics |
Bought by CytoBioscience, Dec 2016 |
| Solvay |
Bought by Abbott 2010 |
| Somaxon Pharmaceuticals |
Bought by Pernix Mar 2013, Renamed Pernix Sleep |
| Somerset Pharmaceuticals |
Acquired by Mylan, Jul 2008 |
| Somna Therapeutics |
Acquired by Restech, Jun 2020 |
| SoniTrack Systems |
Acquired by Zimmer Biomet, Jun 2016 |
| Sonoma Orthopedics |
Acquired by Arthrex, Jul 2017 |
| Sourcia |
Acquired by Alira Health, Apr 2022 |
| Spatial Transcriptomics |
Acquired by 10x Genomics, Dec 2018 |
| SpecialTeam |
Assets Acquired by Desco, Dec 2013 |
| Specifar Pharmaceuticals |
Acquired by Watson Pharmaceuticals, May 2011, $562M |
| Specific Diagnostics |
Acquire by bioMérieux, May 2022 |
| Spectranetics |
Acquired by Philips, Aug 2017, $1.9B |
| Spectrum Laboratories |
Bought by Repligen, Aug 2017, $359M |
| Speedel Pharma |
Bought by Novartis, Jul 2008, $880M |
| Sphinx Pharmaceuticals |
Acquired by Eli Lilly Mar 1994 |
| Spinal Dynamics |
Acquired by Medtronic, Jun 2002, $270M |
| Spinal Kinetics |
Acquired by Orthofix, Mar 2018, $105M |
| Spinifex Pharmaceuticals |
Bought by Novartis, $200M + milestones, Jul 2015 |
| Spinnovation Biologics |
Acquired by Sinensis Life Sciences, Oct 2014 |
| Spiral Genetics |
Acquired by Omicia, Jan 2017 |
| Spiration |
Acquired by Olympus, Jun 2010 |
| Spirogen |
Bought by AstraZeneca, Oct 2013 |
| Spirosure |
Acquired by Caire, Jun 2020; fka Spirometrix |
| Spirox |
Bought by Stryker, Jul 2017 |
| Springborn Laboratories |
Acquired by Charles River Labs, Oct 2002 |
| SQN Clinical |
Acquired by Veristat, Feb 2021 |
| SSCI |
Bought from Aptuit by AMRI, Jan 2015 |
| SSS International Clinical Research |
Acquired by Optimapharma Group, Dec 2021 |
| St. Jude Medical |
Acquired by Abbott, Jan 2017, $25B |
| Stage Cell Therapeutics |
Bought by Juno Therapeutics, May 2015, €52.5 million |
| SteadyMed |
Acquired by United Therapeutics, Aug 2018, $75M + $150M milestones |
| Stealth Biologics |
Acquired by Occulo, Apr 2018 |
| Stelios Therapeutics |
Acquired by LEXEO Therapeutics, Jul 2021 |
| StelKast |
Acquired by Globus Medical, Sep 2019, $24.1M + $4.3M milestones |
| Stellar Biotechnologies |
Acquired/Merged with Edesa Biotech, Jun 2019 |
| Stemcentrx |
Bought by AbbVie, Apr 2016, $5.8B +$4B milestones |
| Stemgent |
Acquired by ReproCELL, Sep 2014 |
| Stiefel |
Acquired by GSK |
| Stimgenics |
Acquired by Medtronic, Jan 2020 |
| Strand Diagnostics |
Acquired by P4 Diagnostix, Feb 2020 |
| Stratagene |
Acquired by Agilent, Apr 2007, $246M |
| StrataGent Life Sciences |
Acquired by Corium, 2007 |
| Stratatech |
Bought by Mallinckrodt, Aug 2017, $76M + $121M milestones |
| Strategic Diagnostic Antibodies |
Acquired by Fitzgerald Industries, 2004 |
| Strativa Pharmaceuticals |
Bought by Par Pharmaceutical, Sep 2007 |
| Stratos Genomics |
Acquired by Roche, May 2020 |
| Stromedix |
Bought by Biogen Idec 2012 |
| Strongbridge Biopharma |
Acquired by Xeris, Oct 2021, $267M; fka Cortendo |
| Stuart Pharmaceuticals |
Acquired by Atlas Chemical Industries |
| Sucampo Pharmaceuticals |
Acquired by Mallinckrodt, Feb 2018 |
| Sugen |
Acquired by Pharmacia & Upjohn, 1999, $650M stock; Shut down 2003 |
| Sun Pharm Corp |
Acquired by Geltex Pharmaceuticals |
| Sunesis Pharmaceuticals |
Acquired by Viracta Therapeutics, Feb 2021 |
| Sunstone BioSciences |
Acquired by Intelligent Material Solutions, 2010 |
| superDimension |
Acquired by Covidien May 2012 |
| Suppremol |
Acquired by Baxter, Mar 2015, €225M, part of Baxalta now |
| Surface Logix |
Bought by Nano Terra |
| Surgical Specialties |
Renamed Corza Medical after acquisition/merger |
| SurgiQuest |
Acquired by ConMed, Jan 2016, $265M |
| SurgRx |
Acquired by Ethicon, Aug 2008 |
| Suros Surgical Systems |
Bought by Hologic, Jul 2006, $240M |
| Swift Biosciences |
Acquired by Integrated DNA Technologies, Mar 2021 |
| SwiftScale Biologics |
Acquired by Resilience, Dec 2021 |
| Swissfillon |
Acquired by ten23, Oct 2021 |
| Symbient Product Development |
Acquired by Gener8, Feb 2020 |
| Symbiomix Therapeutics |
Acquired by Lupin, Oct 2017, $150M |
| Symetis |
Acquired by Boston Scientific, May 2017, $435M |
| Symmetry medical |
Acquired by Tecomet, Dec 2014 |
| Symphogen |
Acquired by Servier, Jun 2020 |
| Synageva BioPharma |
Acquired by Alexion, Jun 2015, $8.4B |
| Synaptic Pharmaceuticals |
Acquired by Lundbeck, Nov 2002 |
| Synbiotics |
Acquired by Pfizer Dec 2010. Included in Zoetis spinout |
| SynCo Bio Partners |
Acquired by Wacker, May 2018 |
| Syndesi Therapeutics |
Acquired by AbbVie, Mar 2022, $130M + $870M milestones |
| Synergen |
Bought by Amgen 1994 |
| Synergetics USA |
Acquired by Valeant, Sep 2015, $190M; Neurosurgical portfolio sold to Stryker, Feb 2016 |
| Synergx |
Owned by Morphogenesis |
| Synergy Health |
Acquired by Steris, Nov 2015 |
| Synergy Pharmaceuticals |
Acquired by Bausch Mar 2019; Bankrupt, Dec 2018, want to accept Bausch bid $200M for assets, auction forthcoming |
| Synosia Therapeutics |
Acquired by Biotie |
| Synovel Sciences |
Bought by Fountain Pharma, Jan 2017 |
| Synpromics |
Acquired by AskBio, Aug 2019 |
| Syntagon |
Acquired by Ardena, May 2018 |
| Synthes |
Acquired by Johnson & Johnson, Jun 2012, $19.7B |
| Synthorx |
Acquired by Sanofi, Jan 2020, $2.5B |
| Syntimmune |
Acquired by Alexion, Nov 2018, $400M + $800M milestones |
| Syntonix Pharmaceuticals |
Acquired by Biogen, Jan 2007 |
| Syrrx |
Acquired by Takeda, Feb 2005, $270M |
| Systagenix |
Acquired by KCI, Oct 2013, $485M |
| SyStemix |
Acquired by Novartis, Jan 1997 |
| Systems Medicine |
Acquired by CTI Jul 2007 |
| T-cell Factory |
Bought by Kite Pharma Mar 2015 €20M |
| Tacere Therapeutics |
Bought by Benitec Biopharma Oct 2012 |
| Talaria Therapeutics |
Acquired by Esperion Therapeutics, Oct 2000, $7.3M shares |
| Talent Biotechs |
Bought by Kalytera Therapeutics, Mar 2017, $10M + $20M milestones |
| Taligen Therapeutics |
Acquired by Alexion |
| Talon Therapeutics |
Bought by Spectrum Pharmaceuticals Jul 2013 |
| Tamir Biotechnology |
Acquired by Orgenesis, Apr 2020 |
| Tandem Laboratories |
Bought by LabCorp, 2008 |
| Tandem Life |
Acquired by LivaNova, Feb 2018 |
| TangenX |
Acquired by Novasep 2006, sold to Repligen, Dec 2016, $39M |
| Tangshian Yian Biological Engineering |
Acquired by Sinovac |
| Tanox |
Acquired by Genentech, Aug 2007, $919M |
| TAP Pharmaceuticals |
Acquired by Takeda |
| Tara Biosystems |
Acquired by Valo Health, Apr 2022 |
| Tarbis Farma |
Acquired by Hetero Labs, Jan 2019 |
| Targanta |
Bought by The Medicines Company |
| TargeGen |
Bought by Sanofi 2010 |
| Target Therapeutics |
Bought by Boston Scientific, Jan 1997 |
| Taris Biomedical |
Acquired by J&J, Dec 2019 |
| Tarsa Therapeutics |
Product rights acquired |
| Tarus Therapeutics |
Acquired by Portage Biotech, Jul 2022 |
| Taueret Laboratories |
Acquired by Predictive Technology Group, Mar 2019 |
| Taurus Biosciences |
Acquired by Ligand Pharmaceuticals, Sep 2020, $5M |
| Taxon Biosciences |
Acquired by DuPont, Apr 2015 |
| TearScience |
Acquired by J&J, Nov 2017 |
| TEI Biosciences |
Bought by Integra Life Sciences, Jun 2015 |
| Telesta Therapeutics |
Bought by ProMetic, Aug 2016, $34M |
| Tenaxis Medical |
Bought by The Medicines Company, Sep 2013 |
| Tendyne Holdings |
Acquired by Abbott, Sep 2015, $225M |
| TeneoBio |
Acquired by Amgen, Oct 2021, $900M; fka OMT Therapeutics |
| TeneoTwo |
Acquired by AstraZeneca, Aug 2022 |
| Tensha Therapeutics |
Acquired by Roche, Jan 2016, $115M + $420 Milestones |
| Tepha Medical Devices |
Acquired by BD, Jul 2021 |
| Tercica |
Bought by Ipsen, Oct 2008 |
| TerraGen Discovery |
Acquired by Cubist Aug 2000, $31M stock |
| Tesaro |
Acquired by GSK, Jan 2019, $5.1B |
| TetraGenetics |
Acquired by AbCellera, Sep 2021 |
| Tetraphase Pharmaceuticals |
Acquired by La Jolla Pharmaceuticals, Jul 2020, $43M |
| Tetris Pharma |
Acquired by Arecor Therapeutics, Aug 2022 |
| TGA Sciences |
Acquired by Absorption Systems, Dec 2017 |
| Thallion Pharmaceuticals |
Bought by Taro Mar 2017; Bought by Bellus Health, Aug 2013 |
| Thar Pharmaceuticals |
Acquired by Grünenthal, Nov 2016 |
| The Medicines Company |
Acquired by Novartis, Jan 2020, $9.7B |
| The Tech Group |
Acquired by West Pharma, May 2016 |
| The Weinberg Group |
Acquired by ProPharma Group, Jan 2019 |
| Themis Bioscience |
Acquired by Merck KgAA/MSD Jun 2020 |
| Theorem Clinical Research |
Bought by Chiltern, Sep 2015 |
| Therabron Therapeutics |
Bought by Brace Pharma Capital Jan 2015 |
| TheraCell |
Acquired by Isto Biologics, Apr 2022 |
| Therachon |
Bought by Pfizer, Jul 2019, $340M + $470M milestones |
| Therapeia |
Program Acquired by Telix, Jan 2017 |
| Therapeutic Human Polyclonals |
Acquired by Roche, Apr 2007, $56.5M |
| Therapure Biopharma |
Acquired by Resilience, Apr 2021 |
| TheraSense |
Acquired by Abbott, Jan 2004, $1.2B |
| Theravant |
Assets acquired by STRATA Skin Sciences |
| Therics |
Acquired by Integra |
| TherOx |
Acquired by Zoll, Jun 2019 |
| Therox Pharmaceuticals |
Acquired by OXIS International, Jul 1995 |
| Thievon-Wright Consulting Group |
Acquired by ERG Clinical, Apr 2018 |
| Third Wave Technologies |
Acquired by Hologic Jun 2008 |
| Thoratec |
Bought by St. Jude Medical, Oct 2015, $3.4B |
| Thrive Earlier Detection |
Acquired by Exact Sciences, Oct 2020, $2.15B |
| Tibotec Therapeutics |
Bought by JnJ, now Janssen Therapeutics |
| Tidal Therapeutics |
Acquired by Sanofi, Apr 2021, $160M + $310M milestones |
| TiGenix |
Acquired by Takeda, Jul 2018, $630M |
| Tilos Therapeutics |
Acquired by Merck, Jun 2019, up to $773M |
| TISSUE SOLUTIONS |
Acquired by BioIVT, Jul 2021 |
| Titan Spine |
Bought by Medtronic, Jun 2019 |
| Tmunity Therapeutics |
Acquired by Kite Therapeutics, Feb 2023 |
| TNI Medical |
Acquired by Masimo, Mar 2020 |
| Tobira Therapeutics |
Bought by Allergan, Nov 2016, $600M + milestones |
| Tocris Bioscience |
Acquired by Bio-Techne, 2011 |
| Tolero Pharmaceuticals |
Rolled in Sumitomo Dainippon Pharma Oncology, Jun 2020; Acquired by Sumitomo Dainippon Pharma, Jan 2017 |
| TomegaVax |
Acquired by Vir Biotechnology, Jan 2017 |
| TomoTherapy |
Bought by Accuray, Mar 2011, $277M |
| Tonbo Biosciences |
Acquired by Cytek Biosciences, Nov 2021 |
| Tongjitang Chinese Medicines Company |
Bought by Winteam Pharmaceutical |
| Topaz Pharma |
Bought by Sanofi Pasteur 2012 |
| Topera Medical |
Acquired by Abbott, 2014, renamed Abbott Electrophysiology |
| Topokine Therapeutics |
Acquired by Allergan, Apr 2016, $85M + milestones |
| TopoTarget USA |
Sold to Apricus Bio, Dec 2011 |
| Topstone Research |
Acquired by Veristat, Oct 2018 |
| TORAX Medical |
Acquired by Ethicon, Mar 2017 |
| toSense |
Acquired by Baxter, Jun 2020 |
| Totient |
Acquired by Absci, Jul 2021 |
| Toxikon |
|
| Transcend Medical |
Acquired by Alcon, Feb 2016, up to $740M |
| Transferra Nanosciences |
Acquired by Evonik Jun 2016; fka Northern lipids |
| Transform Pharmaceuticals |
Bought by JnJ 2005 |
| Transition Therapeutics |
Bought by Opko, $60M stock, Jul 2016 |
| Transkaryotic Therapies |
Acquired by Shire, 2005 |
| Translate Bio |
Acquired by Sanofi, Sep 2021, $3.2B; fka RaNa Therapeutics |
| TransMolecular |
Assets Sold to Eisai 2011 |
| Transmotion Medical |
Assets acquired by Winco, Jun 2015 |
| TransPharma Medical |
Assets acquired by Syneron, Mar 2012 |
| Transport Pharmaceuticals |
Purchased by NitricBio, Oct 2009 |
| Travanti Pharma |
Acquired by Teikoku Pharma, May 2009 |
| Trevigen |
Acquired by Bio-Techne, Sep 2017 |
| Triad Isotopes |
Acquired by Jubilant, Jun 2019 |
| Triad Therapeutics |
Acquired by Monogram Energy Oct 2009 |
| Triangle Pharmaceuticals |
Acquired by Gilead, 2003, $464M |
| Triangle Research Labs |
Acquired by Lonza, Jun 2016 |
| Trianni |
Acquired by AbCellera, Nov 2020, $90M |
| Triax Pharmaceuticals |
Acquired by Onset Dermatology |
| TrichoScience Innovations |
Owned by RepliCel Life Sciences |
| Trigenesis Therapeutics |
Acquired by Dr. Reddy's Laboratories |
| TRIGR Therapeutics |
Acquired by Compass Therapeutics, Jun 2021, $50M |
| Trilliant Surgical |
Acquired by DJO, Jan 2021 |
| Trillium Therapeutics |
Acquired by Pfizer, Nov 2021, $2.3B |
| Trimb Healthcare |
Acquired by Karo Pharma, Sep 2019 |
| Trinity Pharmaceuticals |
Acquired by Chiesi Farmaceutici, 1999 |
| Tripos |
Bought by Certara |
| Trius Therapeutics |
Acquired by Cubist Sep 2013 |
| Trophos |
Acquired by Roche, Jan 2015, €120M + €350 milestones |
| Trubion Pharmaceuticals |
Acquired by Emergent BioSolutions Aug 2010, $97M |
| True North Therapeutics |
Acquired by Bioverativ, Jun 2017, $400M + $425M milestones; Spinout from iPerian, 2013 |
| TRx Pharmaceuticals |
Acquired by Cerecor, Nov 2017 |
| tte laboratories |
Acquired by Transcat |
| Tularik |
Bought by Amgen, Mar 2004, $1.3B |
| Turning Point Therapeutics |
Acquired by BMS, Aug 2022, $4.1B; fka TP Therapeutics |
| Tusk Therapeutics |
Acquired by Roche, Sep 2018, $81M + $679M milestones; Team spinning out into new company Black Belt Therapeutics |
| Tusker Medical |
Acquired by Smith & Nephew, Jan 2020 |
| Tute Genomics |
Acquired by PierianDx, Oct 2016 |
| Twelve |
Bought by Medtronic, Aug 2015, $458M |
| Twelve Bio |
Acquired by Ensoma, Feb 2023 |
| TxCell |
Bought by Sangamo, Oct 2018, $84M |
| TyrNovo |
Bought by Kitov Therapeutics, Jan 2017, $2M + $1.8M stock |
| TYRX |
Acquired by Medtronic, Jan 2014, $160M |
| U3 pharma |
Bought by Daiichi Sankyo, May 2008, $235M; closed 2015 |
| UDL Laboratories |
Acquired by Mylan 1996 |
| Ultransonix |
Acquired by Analogic, Mar 2013, $83M |
| UmanDiagnostics |
Acquired by Quanterix, Jun 2019, $16M cash+$6.5M stock |
| Unimed Pharmaceuticals Inc |
Acquired by Solvay Jun 1999 |
| URL Pharma |
Bought by Takeda Apr 2012, Bought by Sun Pharma Dec 2012 |
| Urogenix |
Acquired by Astellas |
| US Diagnostics |
Bought by Alere, Jul 2015, $60M |
| US Endoscopy |
Acquired by Steris, Jul 2012 |
| US Labs |
Bought by Labcorp |
| Valence Health |
Acquired by Evolent Health, Oct 2016 |
| ValenzaBio |
Acquired by Acelyrin, Jan 2023 |
| Valeritas |
Acquired by Zealand Pharma, Feb 2020, $23M |
| Valocor Therapeutics |
Acquired by Dermira, Oct 2011 |
| Valtech Cardio |
Acquired by Edwards Lifesciences, Jan 2017, $340M |
| ValueGene |
Acquired by Integrated DNA Technologies, Jun 2016 |
| Vanadis Diagnostics |
Bought by PerkinElmer, Jan 2016 |
| Vandalia Research |
Assets acquired by Applied DNA Sciences, $1.5M, Sep 2015 |
| Vanrx Pharmasystems |
Acquired by Cytiva, Feb 2021 |
| VARIAGENICS |
Acquired by Hyseg Pharmaceuticals, Nov 2002, $55.9M |
| Vascular Insights |
Assets acquired by Merit Medical, Jan 2019 |
| Vascular Solutions |
Acquired by Teleflex, Dec 2016 |
| VasoGen |
Assets acquired in complex transaction by Intellipharmaceutics, Oct 2009 |
| VasoNova |
Acquired by Teleflex Medical |
| VaxDesign |
Acquired by Sanofi Pasteur, Sep 2010, $55M |
| VaxGen |
Acquired by diaDexus, Jul 2010 |
| VCN Biosciences |
Acquired by Synthetic Biologics, Mar 2022 |
| Vedere Bio |
Renamed Vedere Bio II ayfter most assets acquired by Novartis, Oct 2020, $150M + $130M Milestones |
| Velano Vascular |
Acquired by BD, Jul 2021 |
| Velesco Pharmaceutical Services |
Acquired by Pace Analytical, Oct 2021 |
| Velocity Medical Solutions |
Acquired by Varian Medical, Apr 2014 |
| Velos |
Acquired by WCG, Mar 2018 |
| VelosBio |
Acquired by Merck, Oct 2020, $2.75B |
| Velquest |
Bought by Accelrys Jan 2012 |
| Veniti |
Acquired by Boston Scientific, Aug 2018, $108M + milestones (already owned 25%) |
| Ventana |
Acquired by Roche, Jan 2008 $3.4B |
| VentiRx Pharmaceuticals |
Apparently acquired by Celgene |
| Veran Medical Technologies |
Acquired by Olympus, Dec 2020, $340M |
| VeraSci |
Acquired by WCG, Jul 2021; fka Neurocog Trials |
| Verb Surgical |
Acquired by J&J Dec 2019 |
| Verenium |
Bought by BASF, Dec 2013 |
| Veridex |
Bought by J&J, now Part of Janssen Diagnostics |
| Verinata Health |
Acquired by Illumina, Jan 2013, $350M+ |
| Verisante Technology |
Acquired via Reverse Merger and seems to have left life sciences, Apr 2018 |
| Verlyx Pharma |
Acquired by Odan Laboratories, Dec 2018; fka Oncozyme Pharma, McGill spinout |
| VeroPharm |
Acquired by Abbott, Dec 2014, $495M |
| Verrow Pharmaceuticals |
Acquired by Ligand Pharmaceuticals, Jan 2018, $2M |
| Versantis |
Acquired by genfit, Sep 2022, CHF40M + CHF65M milestones |
| Vertera Spine |
Bought by NuVasive, Sep 2017 |
| Vertiflex |
Acquired by Boston Scientific, Jun 2019, $465M |
| Vessix Vascular |
Acquired by Boston Scientific, Nov 2012, $425M |
| Vexim |
Acquired by Stryker, Feb 2018, $216M |
| Via Biomedical |
Acquired by Heraeus Medical, Sep 2019 |
| Viagene |
Acquired by Chiron, Apr 1995, $95M |
| Viamet Pharmaceuticals |
Acquired by NovaQuest Capital Management, assets put into new company Selenity Therapeutics, Jan 2018 |
| Viasys Healthcare |
Acquired by Cardinal Health, May 2007, $1.5B |
| Viatris (1) |
Acquired by Meda, Aug 2005, €750M |
| Vicept Therapeutics |
Acquired by Allergan, 2011 |
| Victory Pharma |
Assets Acquired by Shionogi |
| Vicuron Pharmaceuticals |
Acquired by Pfizer (2005) then sold to Durata (2010) |
| Vidara Therapeutics |
Acquired by Horizon Pharma, Sep 2014 |
| Viela Bio |
Acquired by Horizon Therapeutics, Mar 2021, $3B; MedImmune spinout |
| Vigene Biosciences |
Acquired by Charles River, Jun 2021, $292M + $57M milestones |
| Vintage Pharmaceuticals |
Acquired by Apax Partners, Sep 2007, now part of Endo |
| Viracor-IBT |
Renamed Viracor Eurofins; Bought by Eurofins, May 2014 |
| Viralytics |
Bought by Merck KGaA, Jun 2018, $394M |
| Virapur |
Acquired by Microbiologics, 2017 |
| ViraTherapeutics |
Bought by Boehringer Ingelheim, Sep 2018, $244M |
| Virco |
Bought by J&J |
| Virdante Pharmaceuticals |
Assets acquired by Momenta |
| Viridian Pharma |
Acquired by Martindale Pharma, Jul 2016 |
| Viridus Animal Health |
Bought by Huvepharma, Mar 2014 |
| ViroCyt |
Acquired by Sartorius, Jul 2016, $16M; Spun out of InDevR |
| ViroMed Laboratories |
Acquired by LabCorp, Jun 2001 |
| ViroPharma |
Bought by Shire Jan 2014 |
| Viroxis |
Acquired by an oil company, folded into Santalis, Jun 2015 |
| Virttu Biologics |
Acquired by TNK Therapeutics, Apr 2017 |
| VisEn Medical |
Acquired by PerkinElmer, 2010 |
| Visterra |
Acquired by Otsuka, Sep 2018, $430M |
| Vitae Pharmaceuticals |
Bought by Allergan, Sep 2016, $639M |
| Vitaeris |
Bought by CSL Behring, Jun 2020 |
| Vitalea Science |
Acquired by Eckert & Ziegler, Sep 2012, now called Eckert & Ziegler Vitalea Science |
| VitalMED |
Acquired by Kelpac, Jan 2016 |
| Vitrology |
Acquired by SGS, May 2012 |
| Vium |
Acquired by Recursion Pharma, Jul 2020 |
| VivaBioCell |
Acquired by NantCell, Jun 2015 |
| Viventia |
Acquired by Eleven Bio, Sep 2016, $30M in stock |
| Vivo BioSciences |
Acquired by LifeNet health, Nov 2016 |
| Vivopath |
Acquired by Charles River, Jul 2014 |
| vivoPharm |
Acquired by Cancer Genetics, Aug 2017, $12M |
| VNUS Medical Technologies |
Bought by Covidien, May 2009, $440M |
| Volcano |
Bought by Philips, Dec 2014, $1.2B |
| Volumetric |
Acquired by 3D Systems, Oct 2021 |
| Vtesse |
Acquired by Sucampo Pharmaceuticals, Apr 2017, $200M; Spunout of Cyden Orphan drug accelerator |
| VWR |
Bought by Avantor Sciences, Nov 2017, $6.5B |
| WaferGen Biosystems |
Acquired by Takara Bio, Mar 2017, $50M |
| Wako Diagnostics |
Acquired by Fujifilm, Dec 2016 |
| Walk Vascular |
Acquired by Abbott, Sep 2021 |
| Warden Bio |
Acquired by Kriya Therapeutics, Jan 2022 |
| Warner Chilcott |
Acquired by Actavis, Oct 2013 |
| Warner-Lambert |
Bought by Pfizer Feb 2000 $90B |
| Warp Drive Bio |
Assets moved into Revolution Medicines, Sep 2018 |
| Watson Pharmaceuticals |
Acquired Actavis, Oct 2012, took their name |
| WCCT Global |
Acquired by Altasciences, Feb 2021 |
| WCG Intrinsic Imaging |
Acquired by WCG, Jul 2021 |
| WDPrx - Woodfield Pharmaceutical |
Acquired by Reliable HealthCare Logistics |
| WDSrx –Woodfield Distribution |
Acquired by Reliable HealthCare Logistics |
| WIL Research |
Bought by Charles River, Apr 2016, $585M |
| Wilson Therapeutics |
Acquired by Alexion, May 2018, $855M |
| Wolfe Laboratories |
Acquired by Pace Analytical, Dec 2017 |
| Woodland Biosciences |
Acquired by Ichor Life Sciences, Sep 2021 |
| Wyeth |
Bought by Pfizer |
| X-BODY |
Bought by Juno Therapeutics, Jun 2015, $21M + stock + milestones |
| X-Ceptor |
Acquired by Exelixis, Sep 2004, $22.3M |
| X-spine |
Bought by Bacterin, Jul 2015, $73M, combined with Bacterin to become Xtant Medical |
| Xanthus Pharmaceuticals |
Acquired by Antisoma, Jun 2008 |
| Xceleron |
Acquired by Pharmaron, Jan 2017 |
| Xcelience |
Acquired by Capsugel, Jan 2016 |
| xCella Biosciences |
Acquired by Ligand Pharmaceuticals, Sep 2020, $7M |
| Xcellerex |
Acquired by GE Healthcare, May 2012 |
| Xcyte Therapies |
Assets sold, shell sold to Cyclacel, Dec 2005 |
| Xendo |
Acquired by ProPharma, Jul 2018 |
| XenoBiotic Laboratories |
Acquired by WuXi Apptec, Oct 2011 |
| XenoGesis |
Acquired by Sygnature Discovery, Oct 2020 |
| Xenometrics |
Acquired by Citoxlab, Oct 2017 |
| XenoPort |
Acquired by Arbor Pharmaceuticals, Jul 2016, $467M |
| Xenotrans |
Assets purchased by Revivicor, Jun 2005 |
| Xenova |
Acquired by Celtic Pharma |
| Xeridiem |
Acquired by Spetcrum Plastics |
| Xhale |
Acquired by Philips, Aug 2018 |
| Xlumena |
Acquired by Boston Scientific Apr 2015, $62.5M |
| XO1 |
Bought by J&J, Mar 2015 |
| Xtal BioStructures |
Acquired by Schrödinger, Jan 2022, $6M |
| Xycrobe Therapeutics |
Acquired by Crown Laboratories, May 2019 |
| YM Biosciences |
Bought by Gilead Dec 2012 |
| Yumanity Therapeutics |
Reverse merged with Kineta, Dec 2022 |
| Z-Factor |
Centessa Company |
| Z-Medica |
Acquired by Teleflex, Jan 2021, $500M + $25M milestones |
| Zacharon Pharmaceuticals |
Acquired by Biomarin Jan 2013 |
| ZaltanPharma |
Acquired by Riemser, Oct 2019 |
| Zars Pharma |
Acquired by NuVo Research |
| Zavante Therapeutics |
Bought by Nabriva Therapeutics, Aug 2018, 8.2M shares |
| ZebiAI Therapeutics |
Acquired by Relay Therapeutics, Apr 2021, $85M |
| Zeltiq |
Bought by Allergan, Feb 2017, $2.4B |
| Zenyth Therapeutics |
Acquired by CSL, Nov 2006 |
| Zephyrus Biosciences |
Bought by biotechne, Mar 2016; Spun out of Berkeley |
| Zevacor |
Acquired by Sofie Biosciences, Sep 2017 |
| Zevacor Molecular |
Acquired by Curium, Mar 2020 |
| Ziarco |
Bought by Novartis, Dec 2016 |
| Zikani Therapeutics |
Acquired by Eloxx Pharmaceuticals, Apr 2021; fka Macrolide Pharmaceuticals |
| Zila |
Bought by Tolmar, Jul 2009 |
| Zinsser Analytic |
Acquired by Gardner Denver |
| Zipline Medical |
Acquired by Stryker, Jul 2018, $9M |
| Ziylo |
Bought by Novo Nordisk, Jul 2018, up to $800M |
| Zogenix |
Acquired by UCB, Mar 2022, $1.9B |
| Zonare |
Bought by Mindray, Jul 2013, $64M |
| Zosano Pharma |
Acquired by Emergex out of Chapter 11 bankruptcy Aug 2022, $1M |
| zPREDICTA |
Acquired by Predictive Oncology, Dec 2021 |
| ZS Pharma |
Bought by AstraZeneca Nov 2015, $2.7B |
| Zycos |
Acquired by MGI Pharma, Sep 2004, $50M |
| Zyga Technology |
Acquired by RTI Surgical, Jan 2018 |
| Zylera Pharmaceuticals |
Acquired by Cerecor, Nov 2017 |
| Zymenex |
Acquired by Chiesi, Aug 2013 |
| Zymetis |
Acquired by AE Biofuels 2011 |
| Zymogenetics |
Bought by BMS, Sep 2010, $885M |
| ZyStor |
Bought by BioMarin, closed |
